Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	17272044	17272044	A	G	exonic	CROCC	.	synonymous SNV	CROCC:NM_014675:exon15:c.A2079G:p.T693T	4.71E-20	0.643040868	0.356959132	.	.	0.15832	2.431142199	98.53149328	3783.54242	12.05321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	216	chr1	17272044	chr1:17272044	A	G	84	PASS	AN=2;DP=216	GT	0/1
chr1	19018335	19018335	C	T	exonic	PAX7	.	nonsynonymous SNV	PAX7:NM_001135254:exon5:c.C674T:p.T225M,PAX7:NM_002584:exon5:c.C674T:p.T225M,PAX7:NM_013945:exon5:c.C668T:p.T223M	0.6298293	0.369864652	0.000306048	DISEASE: Rhabdomyosarcoma 2 (RMS2) [MIM:268220]: A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas. {ECO:0000269|PubMed:8187070}. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving PAX7 is found in rhabdomyosarcoma. Translocation t(1;13)(p36;q14) with FOXO1. The resulting protein is a transcriptional activator. {ECO:0000269|PubMed:8187070}.; 	0.89869	0.34974	-1.109541557	6.782259967	76.81981	1.83979	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.27	0.982	H	-4.36	0.973	D	-4.96	0.829	D	0.931	0.931	1.038	0.979	D	0.977	0.993	D	0.634	0.969	D	7.067	0.940	33	0.999	0.988	0.974	0.742	D	c	1.093	0.948	1.000	0.747	0.487	0.133	0	4.98	0.655	7.871	0.854	0.935	0.490	1.000	0.715	0.997	0.653	16.819	0.855	Homeobox domain|Homeodomain-like	.	.	0.5	71	181	chr1	19018335	chr1:19018335	C	T	71	PASS	AN=2;DP=181	GT	0/1
chr1	22033386	22033386	A	-	intronic	USP48	.	.	.	0.999997429	2.57E-06	2.13E-16	.	0.10091	0.10216	-0.556537043	19.72753008	115.55589	2.33734	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	114	chr1	22033385	chr1:22033385	GA	G	57	PASS	AN=2;DP=114	GT	0/1
chr1	22332319	22332319	G	A	intronic	CELA3A	.	.	.	9.82E-08	0.312809271	0.68719063	.	0.69428	0.10766	-0.356299879	29.31115829	985.05923	6.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	179	chr1	22332319	chr1:22332319	G	A	69	PASS	AN=2;DP=179	GT	0/1
chr1	27107159	27107159	G	A	exonic	ARID1A	.	nonsynonymous SNV	ARID1A:NM_006015:exon20:c.G6770A:p.R2257Q,ARID1A:NM_139135:exon20:c.G6119A:p.R2040Q	0.999999997	3.36E-09	9.91E-23	.	0.54895	0.15082	-2.670076378	0.743099788	409.71816	4.24329	0.001	0.784	D	1.0	0.899	D	0.996	0.832	D	0.000	0.843	D	1.000	0.588	D	2.195	0.620	M	0.86	0.468	T	-3.54	0.686	D	0.412	0.936	-0.523	0.678	T	0.277	0.649	T	0.016	0.368	T	4.965	0.668	25.1	0.999	0.994	0.973	0.739	D	c	0.804	0.774	1.0	0.983	0.707	0.730	0	4.6	0.564	9.665	0.979	0.902	0.416	1.000	0.715	1.000	0.888	17.964	0.890	Armadillo-type fold	.	.	0.5	.	123	chr1	27107159	chr1:27107159	G	A	.	PASS	AN=0;DP=123	GT	0/1
chr1	36282441	36282441	-	A	intronic	AGO4	.	.	.	0.990043812	0.009956187	9.81E-10	.	0.08477	0.14026	-0.890882376	10.30313753	19.9687	0.68036	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	157	chr1	36282441	chr1:36282441	G	GA	69	PASS	AN=2;DP=157	GT	0/1
chr1	53308644	53308644	A	C	exonic	ZYG11A	.	nonsynonymous SNV	ZYG11A:NM_001004339:exon1:c.A89C:p.Q30P	.	.	.	.	0.11936	.	0.837848571	88.22835574	323.85912	3.82518	0.006	0.614	D	0.911	0.484	P	0.461	0.446	P	0.199	0.166	U	1	0.810	D	2.095	0.583	M	0.89	0.456	T	-1.43	0.352	N	0.626	0.650	-1.062	0.114	T	0.091	0.348	T	0.041	0.598	D	5.178	0.699	25.5	0.991	0.531	0.671	0.331	D	c	0.116	0.130	1.000	0.747	0.564	0.319	0	4.03	0.459	1.125	0.307	0.939	0.529	1.000	0.715	0.987	0.523	9.272	0.367	.	.	.	0.5	.	144	chr1	53308644	chr1:53308644	A	C	.	PASS	AN=0;DP=144	GT	0/1
chr1	65325970	65325970	C	T	intronic	JAK1	.	.	.	0.99590968	0.00409032	2.26E-11	.	0.95076	0.17388	-1.330032624	4.688605803	66.80502	1.68715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	77	chr1	65325970	chr1:65325970	C	T	59	PASS	AN=2;DP=77	GT	0/1
chr1	89289954	89289954	-	T	intronic	PKN2	.	.	.	0.999995223	4.78E-06	4.75E-15	.	0.52957	0.18687	-1.065444789	7.425100259	146.59854	2.63771	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	27	chr1	89289954	chr1:89289954	A	AT	52	PASS	AN=2;DP=27	GT	0/1
chr1	89446108	89446108	T	-	UTR3	RBMXL1	NM_019610:c.*2229delA;NM_001162536:c.*2229delA	.	.	0.119596956	0.87492457	0.005478474	.	0.20063	.	0.72761005	86.08162302	80.60629	1.89749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.93	82	chr1	89446107	chr1:89446107	AT	A	13.93	PASS	AN=0;DP=82	GT	0/1
chr1	110035318	110035318	-	T	UTR3	ATXN7L2	NM_001350174:c.*147_*148insT;NM_001350175:c.*96_*97insT;NM_001350177:c.*96_*97insT;NM_153340:c.*96_*97insT	.	.	0.718954812	0.280915691	0.000129497	.	0.26286	0.0743	-0.909290275	10.03184713	323.63888	3.82196	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	337	chr1	110035318	chr1:110035318	A	AT	71	PASS	AN=2;DP=337	GT	0/1
chr1	114025435	114025435	T	-	intronic	MAGI3	.	.	.	0.570580157	0.429419836	7.05E-09	.	0.93064	0.10933	-0.925889687	9.754659118	136.27247	2.53739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	219	chr1	114025434	chr1:114025434	CT	C,CTT	98	PASS	AN=2;DP=219	GT	0/1
chr1	114025435	114025435	-	T	intronic	MAGI3	.	.	.	0.570580157	0.429419836	7.05E-09	.	0.93064	0.10933	-0.925889687	9.754659118	136.27247	2.53739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	219	chr1	114025434	chr1:114025434	CT	C,CTT	98	PASS	AN=2;DP=219	GT	0/1
chr1	148890234	148890234	A	G	ncRNA_exonic	LOC101927429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	228	chr1	148890234	chr1:148890234	A	G	.	PASS	AN=0;DP=228	GT	0/1
chr1	153742142	153742142	-	T	intronic	INTS3	.	.	.	0.999997023	2.98E-06	1.24E-17	.	0.51743	0.13588	-1.287751345	5.03066761	26.14611	0.84795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	121	chr1	153742142	chr1:153742142	A	AT	74	PASS	AN=2;DP=121	GT	0/1
chr1	154562629	154562629	-	A	intronic	ADAR	.	.	.	0.907595373	0.092404575	5.12E-08	DISEASE: Dyschromatosis symmetrica hereditaria (DSH) [MIM:127400]: An autosomal dominant pigmentary genodermatosis characterized by a mixture of hyperpigmented and hypopigmented macules distributed on the face and the dorsal parts of the hands and feet, that appear in infancy or early childhood. {ECO:0000269|PubMed:12916015, ECO:0000269|PubMed:15146470, ECO:0000269|PubMed:15659327}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010]: A form of Aicardi-Goutieres syndrome, a genetically heterogeneous disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infection. Clinical features as thrombocytopenia, hepatosplenomegaly and elevated hepatic transaminases along with intermittent fever may erroneously suggest an infective process. Severe neurological dysfunctions manifest in infancy as progressive microcephaly, spasticity, dystonic posturing and profound psychomotor retardation. Death often occurs in early childhood. {ECO:0000269|PubMed:23001123}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1228	0.23648	-0.639268965	16.70794999	78.80238	1.87521	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	138	chr1	154562629	chr1:154562629	C	CA	58	PASS	AN=2;DP=138	GT	0/1
chr1	155059035	155059035	-	G	UTR3	EFNA3	NM_004952:c.*16_*17insG	.	.	0.180564105	0.765883297	0.053552599	.	0.43564	0.13588	0.193034296	66.82000472	606.48242	4.98163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	305	chr1	155059035	chr1:155059035	T	TG	74	PASS	AN=2;DP=305	GT	0/1
chr1	155307999	155307999	-	T	exonic	ASH1L	.	frameshift insertion	ASH1L:NM_018489:exon27:c.8683dupA:p.T2895Nfs*3	1	1.66E-13	1.32E-34	.	0.35554	.	-1.798985783	2.223401746	588.79734	4.92053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	443	chr1	155307999	chr1:155307999	G	GT	77	PASS	AN=2;DP=443	GT	0/1
chr1	155720556	155720556	-	T	intronic	GON4L	.	.	.	0.999998892	1.11E-06	2.27E-19	.	0.14902	0.08718	-1.357871407	4.535267752	369.16949	4.0602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	95	chr1	155720556	chr1:155720556	C	CT	71	PASS	AN=2;DP=95	GT	0/1
chr1	161580116	161580116	G	T	intergenic	HSPA7;FCGR3B	dist=1775;dist=12872	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	141	chr1	161580116	chr1:161580116	G	T	.	PASS	AN=0;DP=141	GT	0/1
chr1	162769510	162769510	-	T	intronic	HSD17B7	.	.	.	0.001754508	0.896172411	0.102073081	.	.	.	0.016664174	55.21939137	643.08042	5.09426	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	119	chr1	162769510	chr1:162769510	C	CT,CTT	70	PASS	AN=2;DP=119	GT	0/1
chr1	162769510	162769510	-	TT	intronic	HSD17B7	.	.	.	0.001754508	0.896172411	0.102073081	.	.	.	0.016664174	55.21939137	643.08042	5.09426	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	119	chr1	162769510	chr1:162769510	C	CT,CTT	70	PASS	AN=2;DP=119	GT	0/1
chr1	164326647	164326647	G	A	intergenic	LOC100422212;PBX1	dist=933666;dist=201950	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	150	chr1	164326647	chr1:164326647	G	A	100	PASS	AN=2;DP=150	GT	0/1
chr1	167893778	167893778	-	A	intronic	MPC2	.	.	.	0.449429467	0.522427122	0.028143411	.	0.22019	0.09609	0.501689326	79.7888653	143.21224	2.60927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	110	chr1	167893778	chr1:167893778	G	GA	67	PASS	AN=2;DP=110	GT	0/1
chr1	168205770	168205770	-	T	intronic	SFT2D2	.	.	.	0.003949651	0.855531759	0.140518591	.	0.10989	.	-0.229483771	36.86010852	10.43983	0.37986	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	126	chr1	168205770	chr1:168205770	G	GT	71	PASS	AN=2;DP=126	GT	0/1
chr1	169757860	169757860	-	T	intergenic	SELE;METTL18	dist=54640;dist=3810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	176	chr1	169757859	chr1:169757859	CT	CTT,C	60	PASS	AN=2;DP=176	GT	0/1
chr1	169757860	169757860	T	-	intergenic	SELE;METTL18	dist=54640;dist=3810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	176	chr1	169757859	chr1:169757859	CT	CTT,C	60	PASS	AN=2;DP=176	GT	0/1
chr1	179271949	179271949	T	-	intronic	SOAT1	.	.	.	1.67E-05	0.96658748	0.03339587	.	0.09058	0.50106	-0.286522835	33.47487615	1212.8663	6.5907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	102	chr1	179271948	chr1:179271948	AT	A,ATT	56	PASS	AN=2;DP=102	GT	0/1
chr1	179271949	179271949	-	T	intronic	SOAT1	.	.	.	1.67E-05	0.96658748	0.03339587	.	0.09058	0.50106	-0.286522835	33.47487615	1212.8663	6.5907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	102	chr1	179271948	chr1:179271948	AT	A,ATT	56	PASS	AN=2;DP=102	GT	0/1
chr1	180945093	180945093	-	A	UTR3	STX6	NM_001286210:c.*612_*613insT;NM_005819:c.*612_*613insT	.	.	0.019849117	0.961753214	0.018397669	.	0.11325	0.17021	-0.538132194	20.26421326	21.51311	0.72474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	90	chr1	180945093	chr1:180945093	C	CA	53	PASS	AN=2;DP=90	GT	0/1
chr1	181768572	181768572	G	A	UTR3	CACNA1E	NM_001205293:c.*602G>A;NM_001205294:c.*602G>A;NM_000721:c.*602G>A	.	.	1	6.60E-14	1.68E-33	.	0.53292	0.32174	-2.708891704	0.713611701	325.12803	3.83322	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	99	chr1	181768572	chr1:181768572	G	A	.	PASS	AN=0;DP=99	GT	0/1
chr1	183498178	183498178	G	T	splicing	SMG7	NM_201568:exon7:c.707+1G>T;NM_001350219:exon9:c.794+1G>T;NM_001174061:exon6:c.581+1G>T;NM_001350220:exon9:c.794+1G>T;NM_001350222:exon7:UTR5;NM_001350221:exon9:c.794+1G>T;NM_173156:exon7:c.707+1G>T;NM_201569:exon7:c.707+1G>T;NM_001331007:exon8:c.794+1G>T	.	.	0.999981493	1.85E-05	5.27E-15	.	0.16156	0.11403	-0.306750577	32.23047889	2354.2528	8.99331	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.026	0.677	25.2	0.995	0.686	0.987	0.860	D	c	1.191	1.031	1.000	0.747	0.295	0.044	0	5.07	0.680	9.079	0.934	0.953	0.551	1.000	0.715	0.965	0.450	18.820	0.920	.	.	.	0.5	61	124	chr1	183498178	chr1:183498178	G	T	61	PASS	AN=2;DP=124	GT	0/1
chr1	198264408	198264408	-	A	intronic	NEK7	.	.	.	0.707657761	0.29219643	0.000145809	.	0.24935	0.11215	-0.029247611	51.40363293	55.39612	1.49342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	192	chr1	198264407	chr1:198264407	CA	CAA,C	58	PASS	AN=2;DP=192	GT	0/1
chr1	198264408	198264408	A	-	intronic	NEK7	.	.	.	0.707657761	0.29219643	0.000145809	.	0.24935	0.11215	-0.029247611	51.40363293	55.39612	1.49342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	192	chr1	198264407	chr1:198264407	CA	CAA,C	58	PASS	AN=2;DP=192	GT	0/1
chr1	204375080	204375080	A	-	UTR3	PPP1R15B	NM_032833:c.*140delT	.	.	0.161223928	0.835586348	0.003189724	.	0.2019	0.08179	0.734883636	86.29983487	244.79842	3.3742	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	119	chr1	204375079	chr1:204375079	CA	C,CAA	57	PASS	AN=2;DP=119	GT	0/1
chr1	204375080	204375080	-	A	UTR3	PPP1R15B	NM_032833:c.*139_*140insT	.	.	0.161223928	0.835586348	0.003189724	.	0.2019	0.08179	0.734883636	86.29983487	244.79842	3.3742	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	119	chr1	204375079	chr1:204375079	CA	C,CAA	57	PASS	AN=2;DP=119	GT	0/1
chr1	205028152	205028152	-	C	intronic	CNTN2	.	.	.	0.129621135	0.870378534	3.31E-07	DISEASE: Epilepsy, familial adult myoclonic, 5 (FAME5) [MIM:615400]: A form of cortical myoclonic tremor with epilepsy, a syndrome characterized by cortical myoclonus and variable occurrence of epileptic seizures. Usually, myoclonic tremor is the presenting symptom, characterized by tremulous finger movements and myoclonic jerks of the limbs increased by action and posture. In a minority of patients, seizures are the presenting symptom; both complex partial as well as generalized tonic clonic seizures are described. Some patients exhibit mild cognitive impairment. {ECO:0000269|PubMed:23518707}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.39019	0.18821	-0.189246284	39.30761972	2533.66697	9.38949	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	70	chr1	205028152	chr1:205028152	A	AC	130	PASS	AN=2;DP=70	GT	0/1
chr1	205719177	205719177	C	-	UTR5	NUCKS1	NM_022731:c.-76delG	.	.	0.979237658	0.020744772	1.76E-05	.	0.90068	0.13281	-0.119252484	44.53880632	4.59039	0.16497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	320	chr1	205719176	chr1:205719176	AC	A	92	PASS	AN=2;DP=320	GT	0/1
chr1	206566861	206566861	A	-	ncRNA_intronic	SRGAP2D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	107	chr1	206566860	chr1:206566860	TA	T	123	PASS	AN=2;DP=107	GT	0/1
chr1	207933082	207933082	T	-	intronic	CD46	.	.	.	0.000191603	0.974855327	0.02495307	DISEASE: Hemolytic uremic syndrome atypical 2 (AHUS2) [MIM:612922]: An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease. {ECO:0000269|PubMed:16386793, ECO:0000269|PubMed:16621965, ECO:0000269|PubMed:20513133}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Other genes may play a role in modifying the phenotype. Patients with CD46 mutations seem to have an overall better prognosis compared to patients carrying CFH mutations.; 	0.10479	0.17659	0.439181676	77.69521113	55.53796	1.49781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	215	chr1	207933081	chr1:207933081	CT	C	66	PASS	AN=2;DP=215	GT	0/1
chr1	243594954	243594954	-	T	intronic	SDCCAG8	.	.	.	1.33E-07	0.987717896	0.012281972	DISEASE: Bardet-Biedl syndrome 16 (BBS16) [MIM:615993]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:20835237, ECO:0000269|PubMed:22626039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13767	0.11503	-0.154246007	42.22694032	1944.53595	8.11749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	216	chr1	243594954	chr1:243594954	A	AT	102	PASS	AN=2;DP=216	GT	0/1
chr1	245005424	245005424	-	T	intronic	COX20	.	.	.	0.011885436	0.640070275	0.348044289	.	0.15623	.	0.080983847	59.76055674	22.69107	0.75925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	181	chr1	245005424	chr1:245005424	A	AT	69	PASS	AN=2;DP=181	GT	0/1
chr2	5834716	5834716	-	T	UTR3	SOX11	NM_003108:c.*537_*538insT	.	.	0.343767037	0.598619703	0.05761326	.	0.41352	0.15395	.	.	8.44037	0.30871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	292	chr2	5834716	chr2:5834716	A	AT	78	PASS	AN=2;DP=292	GT	0/1
chr2	15536509	15536509	-	A	intronic	NBAS	.	.	.	1.89E-25	0.999906723	9.33E-05	DISEASE: Infantile liver failure syndrome 2 (ILFS2) [MIM:616483]: A form of infantile liver failure syndrome, a life-threatening disorder of hepatic function that manifests with acute liver failure in the first few months of life. Clinical features include anemia, renal tubulopathy, developmental delay, seizures, failure to thrive, and liver steatosis and fibrosis. {ECO:0000269|PubMed:26073778}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=NBAS mutations have been found in a multisystem disease affecting the liver, eye, immune system, connective tissue, and bone. Clinical manifestations include a progeroid appearance, short stature, slender bones, epiphyseal dysplasia with multiple phalangeal pseudo-epiphyses, cervical instability, myelopathy, elevated transaminases, hypogammaglobulinemia, reduced natural killer cells, Pelger-Huet anomaly of granulocytes, and in some cases retinal dystrophy and optic atrophy. {ECO:0000269|PubMed:26286438}.; 	.	.	-0.224542487	37.33191791	2659.86206	9.69933	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	120	chr2	15536509	chr2:15536509	G	GA	74	PASS	AN=2;DP=120	GT	0/1
chr2	28836881	28836881	-	T	intronic	PLB1	.	.	.	1.99E-56	1.22E-09	0.999999999	.	0.12087	0.11509	1.208866406	93.05850436	3555.80975	11.53022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	172	chr2	28836881	chr2:28836881	G	GT	66	PASS	AN=2;DP=172	GT	0/1
chr2	55863360	55863360	-	A	UTR3	PNPT1	NM_033109:c.*11_*12insT	.	.	0.908266843	0.091733155	2.06E-09	DISEASE: Combined oxidative phosphorylation deficiency 13 (COXPD13) [MIM:614932]: A mitochondrial disorder characterized by early onset severe encephalomyopathy, dystonia, choreoathetosis, bucofacial dyskinesias and combined mitochondrial respiratory chain deficiency. Nerve conductions velocities are decreased. Levels of plasma and cerebrospinal fluid lactate are increased. {ECO:0000269|PubMed:23084291}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 70 (DFNB70) [MIM:614934]: A form of non-syndromic deafness characterized by severe, bilateral hearing impairment with prelingual onset, resulting in inability to acquire normal speech. {ECO:0000269|PubMed:23084290}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2306	0.0952	0.135991087	63.61759849	3768.17005	12.01066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	183	chr2	55863360	chr2:55863360	T	TA	69	PASS	AN=2;DP=183	GT	0/1
chr2	74291829	74291829	-	T	intronic	TET3	.	.	.	0.999942651	5.73E-05	1.00E-11	.	0.85759	0.1031	-1.512251235	3.479594244	432.06015	4.33811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	386	chr2	74291829	chr2:74291829	A	AT	75	PASS	AN=2;DP=386	GT	0/1
chr2	74687542	74687542	-	C	exonic	WBP1	.	frameshift insertion	WBP1:NM_012477:exon4:c.545dupC:p.H185Sfs*4	0.000303097	0.803000262	0.196696641	.	.	0.10512	-0.26993514	34.59542345	86.33658	1.98463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	598	chr2	74687542	chr2:74687542	G	GC	106	PASS	AN=2;DP=598	GT	0/1
chr2	91793472	91793472	C	A	intergenic	NONE;LOC654342	dist=NONE;dist=31237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	320	chr2	91793472	chr2:91793472	C	A	95	PASS	AN=2;DP=320	GT	0/1
chr2	91885985	91885985	T	C	intergenic	LOC654342;LOC101927050	dist=38010;dist=1729	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	191	chr2	91885985	chr2:91885985	T	C	.	PASS	AN=0;DP=191	GT	0/1
chr2	101881539	101881539	-	T	intronic	CNOT11	.	.	.	0.993507645	0.006491339	1.02E-06	.	0.50975	0.09076	-0.361761279	28.6329323	24.35814	0.80124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	440	chr2	101881539	chr2:101881539	C	CT	105	PASS	AN=2;DP=440	GT	0/1
chr2	109276712	109276712	-	A	intronic	LIMS1	.	.	.	0.347565207	0.649601345	0.002833447	.	0.85268	0.14897	.	.	138.63474	2.56496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	637	chr2	109276712	chr2:109276712	G	GA	98	PASS	AN=2;DP=637	GT	0/1
chr2	112536287	112536287	G	A	exonic	ANAPC1	.	nonsynonymous SNV	ANAPC1:NM_022662:exon45:c.C5350T:p.P1784S	.	.	.	.	0.55585	0.09577	.	.	199.72138	3.0527	0.039	0.424	D	1.0	0.899	D	0.994	0.807	D	0.000	0.504	D	1	0.810	D	2.685	0.788	M	.	.	.	-1.73	0.410	N	0.535	0.574	-0.361	0.733	T	0.400	0.751	T	0.017	0.386	T	5.981	0.822	27.8	0.999	0.963	0.986	0.845	D	c	0.625	0.576	0.998	0.367	0.732	0.924	0	4.05	0.462	9.277	0.949	0.877	0.384	1.000	0.715	1.000	0.888	16.595	0.846	.	.	.	0.5	127	168	chr2	112536287	chr2:112536287	G	A	127	PASS	AN=2;DP=168	GT	0/1
chr2	113379341	113379341	-	GT	intergenic	CHCHD5;FLJ42351	dist=32724;dist=20066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	94	chr2	113379341	chr2:113379341	G	GGT	55	PASS	AN=2;DP=94	GT	0/1
chr2	131947396	131947396	T	-	intergenic	PLEKHB2;POTEE	dist=39971;dist=28528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	404	chr2	131947395	chr2:131947395	AT	A	78	PASS	AN=2;DP=404	GT	0/1
chr2	145027394	145027394	-	A	intronic	GTDC1	.	.	.	2.41E-10	0.07320236	0.92679764	.	0.15283	0.07494	-0.176292081	40.56381222	263.31779	3.48127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.99	88	chr2	145027394	chr2:145027394	T	TA	13.99	PASS	AN=0;DP=88	GT	0/1
chr2	201362423	201362423	-	T	intronic	KCTD18	.	.	.	0.000526111	0.886183067	0.113290821	.	0.22561	.	0.621009802	83.41589998	721.00753	5.33094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	102	chr2	201362423	chr2:201362423	C	CT	62	PASS	AN=2;DP=102	GT	0/1
chr2	204354507	204354507	C	T	exonic	RAPH1	.	nonsynonymous SNV	RAPH1:NM_001329728:exon4:c.G532A:p.D178N,RAPH1:NM_203365:exon4:c.G532A:p.D178N,RAPH1:NM_213589:exon4:c.G532A:p.D178N	0.957851233	0.042148732	3.46E-08	.	0.25984	0.27016	-2.607452819	0.807973579	124.99766	2.43194	0.206	0.682	T	0.804	0.432	P	0.173	0.396	B	0.011	0.299	N	1.000	0.499	D	1.25	0.319	L	0.96	0.460	T	-1.6	0.416	N	0.047	0.043	-0.976	0.360	T	0.113	0.404	T	0.008	0.207	T	2.994	0.420	22.2	0.998	0.882	0.936	0.583	D	c	0.129	0.220	1.000	0.747	0.707	0.730	0	5.33	0.756	2.720	0.467	0.852	0.362	1.000	0.715	0.965	0.450	19.022	0.929	.	.	.	0.5	58	72	chr2	204354507	chr2:204354507	C	T	58	PASS	AN=2;DP=72	GT	0/1
chr2	216967385	216967385	-	A	UTR3	TMEM169	NM_001142311:c.*2120_*2121insA;NM_001142310:c.*2120_*2121insA;NM_138390:c.*2120_*2121insA;NM_001142312:c.*2120_*2121insA	.	.	0.011784537	0.847117338	0.141098125	.	0.08509	.	-0.492218069	22.35786742	116.65375	2.34953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	162	chr2	216967385	chr2:216967385	G	GA	53	PASS	AN=2;DP=162	GT	0/1
chr2	228109625	228109625	-	TG	ncRNA_intronic	LOC654841	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	306	chr2	228109625	chr2:228109625	T	TTG	78	PASS	AN=2;DP=306	GT	0/1
chr2	238632160	238632160	T	-	intronic	LRRFIP1	.	.	.	0.36551249	0.633984856	0.000502654	.	0.11014	0.08981	0.609894095	82.95588582	1129.28257	6.41308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.88	102	chr2	238632159	chr2:238632159	GT	G,GTT	13.88	PASS	AN=0;DP=102	GT	0/1/.
chr2	238632160	238632160	-	T	intronic	LRRFIP1	.	.	.	0.36551249	0.633984856	0.000502654	.	0.11014	0.08981	0.609894095	82.95588582	1129.28257	6.41308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.88	102	chr2	238632159	chr2:238632159	GT	G,GTT	13.88	PASS	AN=0;DP=102	GT	0/1/.
chr2	241979571	241979571	C	T	exonic	SNED1	.	synonymous SNV	SNED1:NM_001080437:exon7:c.C1125T:p.C375C	0.98376281	0.01623719	1.33E-10	.	0.22403	0.13286	-1.379925048	4.364236848	4194.17391	12.86144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	272	chr2	241979571	chr2:241979571	C	T	67	PASS	AN=2;DP=272	GT	0/1
chr2	243061143	243061143	A	G	ncRNA_exonic	LINC01881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	178	chr2	243061143	chr2:243061143	A	G	98	PASS	AN=2;DP=178	GT	0/1
chr3	7620433	7620433	C	G	exonic	GRM7	.	nonsynonymous SNV	GRM7:NM_000844:exon8:c.C1840G:p.R614G,GRM7:NM_181874:exon8:c.C1840G:p.R614G	0.999169069	0.00083093	1.36E-09	.	0.68439	0.09371	-1.616692429	2.937013447	1262.73334	6.70044	0.002	0.721	D	0.953	0.764	P	0.852	0.850	P	0.000	0.843	D	1	0.810	D	3.42	0.921	M	-2.51	0.893	D	-4.83	0.809	D	0.982	0.985	0.854	0.951	D	0.856	0.952	D	0.337	0.919	D	6.731	0.919	32	0.999	0.975	0.960	0.667	D	c	0.797	0.758	1.000	0.747	0.554	0.246	0	5.93	0.959	2.671	0.463	0.935	0.490	0.993	0.376	1.000	0.888	18.918	0.925	GPCR family 3, C-terminal	.	.	0.5	92	195	chr3	7620433	chr3:7620433	C	G	92	PASS	AN=2;DP=195	GT	0/1
chr3	23848923	23848923	-	T	intronic	UBE2E1	.	.	.	0.872957997	0.125383932	0.00165807	.	0.62873	0.11262	0.279402865	70.86577023	246.66235	3.38871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	200	chr3	23848923	chr3:23848923	C	CT	85	PASS	AN=2;DP=200	GT	0/1
chr3	40550121	40550121	-	T	intronic	ZNF620	.	.	.	6.83E-06	0.715071728	0.284921445	.	0.10981	.	0.350995466	74.37485256	198.29097	3.04284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.36	73	chr3	40550121	chr3:40550121	C	CT	10.36	PASS	AN=0;DP=73	GT	0/1
chr3	57140083	57140083	C	A	intronic	IL17RD	.	.	.	2.64E-05	0.98202302	0.017950625	.	0.6749	0.12392	-0.172654315	40.63458363	2297.79347	8.87861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	86	chr3	57140083	chr3:57140083	C	A	.	PASS	AN=0;DP=86	GT	0/1
chr3	62114504	62114504	T	-	intronic	PTPRG	.	.	.	0.004176573	0.995823405	2.16E-08	.	0.72801	0.18321	-1.738187109	2.429818353	1119.45815	6.38788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	146	chr3	62114503	chr3:62114503	AT	A	44	PASS	AN=2;DP=146	GT	0/1
chr3	113207968	113207968	-	T	intronic	SPICE1	.	.	.	5.14E-08	0.990209074	0.009790874	.	0.13123	.	0.249861693	69.66265629	475.73296	4.50529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	15	chr3	113207968	chr3:113207968	C	CT	67	PASS	AN=2;DP=15	GT	0/1
chr3	113368347	113368347	T	-	UTR3	USF3	NM_001009899:c.*5444delA	.	.	.	.	.	.	0.42318	.	-0.711157248	14.50224109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	96	chr3	113368346	chr3:113368346	GT	G	55	PASS	AN=2;DP=96	GT	0/1
chr3	119469924	119469924	C	G	exonic	MAATS1	.	nonsynonymous SNV	MAATS1:NM_001320318:exon15:c.C1906G:p.Q636E,MAATS1:NM_001320317:exon16:c.C2098G:p.Q700E,MAATS1:NM_001320316:exon17:c.C2224G:p.Q742E,MAATS1:NM_033364:exon17:c.C2284G:p.Q762E	9.78E-10	0.904945227	0.095054772	.	0.06869	0.09515	0.872633161	88.87119604	840.25979	5.67623	0.316	0.137	T	0.0	0.026	B	0.002	0.063	B	0.540	0.115	N	1	0.090	N	.	.	.	1.71	0.267	T	-0.37	0.132	N	0.029	0.115	-0.964	0.384	T	0.024	0.104	T	0.004	0.111	T	-1.774	0.011	0.002	0.649	0.074	0.073	0.132	N	c	-1.165	-1.145	0.304	0.192	0.638	0.428	0	0.059	0.136	0.546	0.228	0.841	0.343	0.000	0.063	0.002	0.062	6.517	0.213	.	.	.	0.5	47	45	chr3	119469924	chr3:119469924	C	G	47	PASS	AN=2;DP=45	GT	0/1
chr3	140678384	140678384	-	A	splicing	SLC25A36	NM_018155:exon3:c.284+2->A;NM_001104647:exon3:c.284+2->A	.	.	0.883013619	0.116709235	0.000277146	.	0.16774	0.10791	-0.405853867	26.23260203	27.59314	0.88809	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.93	112	chr3	140678384	chr3:140678384	T	TA	11.93	PASS	AN=0;DP=112	GT	0/1
chr3	147124452	147124452	-	T	UTR5	ZIC4	NM_032153:c.-3869_-3868insA;NM_001243256:c.-3869_-3868insA	.	.	0.001816904	0.900072856	0.09811024	.	0.20879	0.10422	-0.047654689	50.22410946	125.09939	2.43427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	128	chr3	147124452	chr3:147124452	C	CT	69	PASS	AN=2;DP=128	GT	0/1
chr3	160248732	160248732	-	A	intronic	KPNA4	.	.	.	0.998180756	0.001819234	9.21E-09	.	0.86481	0.44724	-0.139478553	43.29440906	13.68591	0.49653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	170	chr3	160248732	chr3:160248732	C	CA	69	PASS	AN=2;DP=170	GT	0/1
chr3	183665256	183665256	-	A	exonic	ABCC5	.	frameshift insertion	ABCC5:NM_001320032:exon23:c.1853dupT:p.L618Ffs*62,ABCC5:NM_005688:exon23:c.3269dupT:p.L1090Ffs*62	0.896205135	0.103794865	2.35E-11	.	0.38723	0.35905	-1.967739992	1.816466148	80.81009	1.89955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	193	chr3	183665256	chr3:183665256	C	CA	74	PASS	AN=2;DP=193	GT	0/1
chr3	184552422	184552422	-	T	intronic	VPS8	.	.	.	3.62E-06	0.999996197	1.85E-07	.	0.13365	0.11078	-0.365622677	28.30856334	3238.91039	10.83959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	44	chr3	184552422	chr3:184552422	C	CT	80	PASS	AN=2;DP=44	GT	0/1
chr3	193209178	193209178	T	C	exonic	ATP13A4	.	nonsynonymous SNV	ATP13A4:NM_032279:exon6:c.A543G:p.I181M	6.08E-10	0.999598041	0.000401958	DISEASE: Note=A chromosomal aberration involving ATP13A4 is found in 2 patients with specific language impairment (SLI) disorders. Paracentric inversion inv(3)(q25;q29). The inversion produces a disruption of the protein. {ECO:0000269|PubMed:15925480}.; 	0.08132	0.09862	-1.383523256	4.358339231	5510.00677	15.30149	0.153	0.282	T	0.998	0.764	D	0.981	0.769	D	0.000	0.629	D	0.109	0.359	P	2.085	0.579	M	-1.2	0.785	T	-1.6	0.387	N	0.226	0.389	-0.935	0.434	T	0.000	0.000	T	.	.	.	4.024	0.541	23.6	0.994	0.623	0.540	0.292	D	c	0.394	0.329	0.008	0.115	0.487	0.133	0	4.63	0.570	-0.414	0.071	1.011	0.635	0.712	0.285	1.000	0.888	9.318	0.369	Cation-transporting P-type ATPase, N-terminal	ENSG00000127249.10|ENSG00000127249.10	Lung|Testis	0.5	132	45	chr3	193209178	chr3:193209178	T	C	132	PASS	AN=2;DP=45	GT	1/0
chr3	195717077	195717077	-	GCGCCAG	ncRNA_exonic	SDHAP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	91	chr3	195717077	chr3:195717077	A	AGCGCCAG	95	PASS	AN=2;DP=91	GT	0/1
chr3	195984818	195984818	-	A	intronic	PCYT1A	.	.	.	0.098300076	0.90012567	0.001574255	DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]: A disorder characterized by postnatal growth deficiency resulting in profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75481	.	-0.846787714	11.05803255	78.82184	1.87555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.05	23	chr3	195984818	chr3:195984818	T	TA	11.05	PASS	AN=0;DP=23	GT	0/1
chr4	997905	997905	G	A	intronic	IDUA	.	.	.	2.64E-08	0.478326206	0.521673767	DISEASE: Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]: A severe form of mucopolysaccharidosis type 1, a rare lysosomal storage disease characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. Patients with MPS1H usually present, within the first year of life, a combination of hepatosplenomegaly, skeletal deformities, corneal clouding and severe mental retardation. Obstructive airways disease, respiratory infection and cardiac complications usually result in death before 10 years of age. {ECO:0000269|PubMed:10466419, ECO:0000269|PubMed:10735634, ECO:0000269|PubMed:12559846, ECO:0000269|PubMed:1301941, ECO:0000269|PubMed:15300847, ECO:0000269|PubMed:21394825, ECO:0000269|PubMed:7550232, ECO:0000269|PubMed:7550242, ECO:0000269|PubMed:7951228, ECO:0000269|PubMed:8019563, ECO:0000269|PubMed:8328452, ECO:0000269|PubMed:8401515, ECO:0000269|Ref.20}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]: A form of mucopolysaccharidosis type 1, a rare lysosomal storage disease characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. MPS1H/S represents an intermediate phenotype of the MPS1 clinical spectrum. It is characterized by relatively little neurological involvement, but most of the somatic symptoms described for severe MPS1 develop in the early to mid-teens, causing considerable loss of mobility. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]: A mild form of mucopolysaccharidosis type 1, a rare lysosomal storage disease characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. Patients with MPS1S may have little or no neurological involvement, normal stature and life span, but present development of joints stiffness, mild hepatosplenomegaly, aortic valve disease and corneal clouding. {ECO:0000269|PubMed:12559846, ECO:0000269|PubMed:15300847, ECO:0000269|PubMed:19396826, ECO:0000269|PubMed:21394825, ECO:0000269|PubMed:25256405, ECO:0000269|PubMed:7550232, ECO:0000269|PubMed:7550242, ECO:0000269|PubMed:8213840}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08409	0.09876	.	.	2688.19258	9.75774	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	97	chr4	997905	chr4:997905	G	A	.	PASS	AN=0;DP=97	GT	0/1
chr4	1087328	1087329	AC	CTGCCCAGGCTGGAGCCAGCCTT	exonic	RNF212	.	nonframeshift substitution	RNF212:NM_001193318:exon4:c.720_721AAGGCTGGCTCCAGCCTGGGCAG:p.S241delinsRLAPAWAA	0.125225584	0.869720008	0.005054408	.	0.13995	.	.	.	166.87321	2.82299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	168	180	chr4	1087328	chr4:1087328	AC	CTGCCCAGGCTGGAGCCAGCCTT,A	168	PASS	AN=2;DP=180	GT	0/1
chr4	1087329	1087329	C	-	exonic	RNF212	.	frameshift deletion	RNF212:NM_001193318:exon4:c.720delG:p.R240Sfs*20	0.125225584	0.869720008	0.005054408	.	0.13995	.	.	.	166.87321	2.82299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	168	180	chr4	1087328	chr4:1087328	AC	CTGCCCAGGCTGGAGCCAGCCTT,A	168	PASS	AN=2;DP=180	GT	0/1
chr4	6711493	6711493	-	T	UTR5	MRFAP1L1	NM_203462:c.-138_-137insA	.	.	0.008908008	0.578868963	0.412223029	.	0.16044	0.11262	0.125076652	62.7388535	42.65034	1.23741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	219	chr4	6711493	chr4:6711493	A	AT	60	PASS	AN=2;DP=219	GT	0/1
chr4	8472786	8472786	A	-	intronic	TRMT44	.	.	.	1.48E-13	0.006885759	0.993114241	.	0.11127	0.07994	.	.	301.17928	3.69794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	171	chr4	8472785	chr4:8472785	GA	G	66	PASS	AN=2;DP=171	GT	0/1
chr4	39459818	39459818	T	-	exonic	RPL9	.	frameshift deletion	RPL9:NM_000661:exon3:c.158delA:p.K53Rfs*27,RPL9:NM_001024921:exon3:c.158delA:p.K53Rfs*27	0.918456438	0.081011629	0.000531934	.	0.99267	0.1069	-0.163345027	41.24793583	8.97949	0.32975	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	428	chr4	39459817	chr4:39459817	CT	C,CTT	73	PASS	AN=2;DP=428	GT	0/1
chr4	39459818	39459818	-	T	exonic	RPL9	.	frameshift insertion	RPL9:NM_000661:exon3:c.157dupA:p.R54Efs*4,RPL9:NM_001024921:exon3:c.157dupA:p.R54Efs*4	0.918456438	0.081011629	0.000531934	.	0.99267	0.1069	-0.163345027	41.24793583	8.97949	0.32975	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	428	chr4	39459817	chr4:39459817	CT	C,CTT	73	PASS	AN=2;DP=428	GT	0/1
chr4	71554691	71554693	GGA	-	exonic	UTP3	.	nonframeshift deletion	UTP3:NM_020368:exon1:c.297_299del:p.E105del	0.002776963	0.93819451	0.059028527	.	0.05932	0.09551	0.795569043	87.49115357	195.12242	3.0281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	47	chr4	71554690	chr4:71554690	GGGA	G	45	PASS	AN=2;DP=47	GT	0/1
chr4	100784134	100784134	C	G	intronic	DAPP1	.	.	.	0.18349368	0.804567476	0.011938844	.	0.18283	0.11376	-0.075159878	47.78839349	10.06314	0.36728	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	305	chr4	100784134	chr4:100784134	C	G	66	PASS	AN=2;DP=305	GT	0/1
chr4	101337123	101337123	-	A	intronic	EMCN	.	.	.	1.65E-05	0.666582651	0.33340082	.	0.31171	.	0.060756528	58.52795471	2740.85611	9.87049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	114	chr4	101337123	chr4:101337123	G	GA	62	PASS	AN=2;DP=114	GT	0/1
chr4	113178967	113178967	A	-	intronic	AP1AR	.	.	.	0.511166929	0.488021686	0.000811385	.	0.14777	0.14109	0.327131069	73.27199811	63.26348	1.62796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.85	166	chr4	113178966	chr4:113178966	TA	T,TAAA	12.85	PASS	AN=0;DP=166	GT	0/1/.
chr4	113178967	113178967	-	AA	intronic	AP1AR	.	.	.	0.511166929	0.488021686	0.000811385	.	0.14777	0.14109	0.327131069	73.27199811	63.26348	1.62796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.85	166	chr4	113178966	chr4:113178966	TA	T,TAAA	12.85	PASS	AN=0;DP=166	GT	0/1/.
chr4	151683004	151683004	A	-	intronic	LRBA	.	.	.	0.044229437	0.955770563	1.54E-17	DISEASE: Immunodeficiency, common variable, 8, with autoimmunity (CVID8) [MIM:614700]: An autosomal recessive immunologic disorder associated with defective B-cell differentiation and decreased or absent antibody production. Affected individuals have early- childhood onset of recurrent infections, particularly respiratory infections, and also develop variable autoimmune disorders, including idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and inflammatory bowel disease. {ECO:0000269|PubMed:22608502}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.31593	.	-2.513092117	0.925925926	4753.32179	13.94798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	139	chr4	151683003	chr4:151683003	TA	T	67	PASS	AN=2;DP=139	GT	0/1
chr4	160253030	160253030	-	T	intronic	RAPGEF2	.	.	.	0.999996667	3.33E-06	1.64E-17	.	0.57738	0.133	-1.658985203	2.724699222	98.637	2.1472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	49	chr4	160253030	chr4:160253030	G	GT	71	PASS	AN=2;DP=49	GT	0/1
chr4	186378975	186378975	-	A	intronic	CCDC110	.	.	.	1.35E-08	0.571522479	0.428477507	.	0.09113	0.08327	3.004392866	99.21561689	2433.27149	9.16393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	38	chr4	186378975	chr4:186378975	G	GA	42	PASS	AN=2;DP=38	GT	0/1
chr5	256379	256379	C	T	intronic	SDHA	.	.	.	9.39E-06	0.996636308	0.003354304	DISEASE: Mitochondrial complex II deficiency (MT-C2D) [MIM:252011]: A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations. Clinical features include psychomotor regression in infants, poor growth with lack of speech development, severe spastic quadriplegia, dystonia, progressive leukoencephalopathy, muscle weakness, exercise intolerance, cardiomyopathy. Some patients manifest Leigh syndrome or Kearns-Sayre syndrome. Note=The disease is caused by mutations affecting the gene represented in this entry. {ECO:0000269|PubMed:12794685}.; DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:10746566, ECO:0000269|PubMed:24781757, ECO:0000269|PubMed:7550341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1GG (CMD1GG) [MIM:613642]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:20551992}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Paragangliomas 5 (PGL5) [MIM:614165]: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion. Paragangliomas can develop at various body sites, including the head, neck, thorax and abdomen. Most commonly, they are located in the head and neck region, specifically at the carotid bifurcation, the jugular foramen, the vagal nerve, and in the middle ear. {ECO:0000269|PubMed:20484225}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2964	.	-0.857930839	10.95187544	1260.39498	6.69421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	138	chr5	256379	chr5:256379	C	T	84	PASS	AN=2;DP=138	GT	0/1
chr5	17632247	17632247	C	G	intergenic	LINC02218;LINC02223	dist=148192;dist=175136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	396	chr5	17632247	chr5:17632247	C	G	.	PASS	AN=0;DP=396	GT	0/1
chr5	36876937	36876937	C	-	UTR5	NIPBL	NM_015384:c.-76862del-;NM_133433:c.-76862del-	.	.	1	9.20E-18	1.38E-43	DISEASE: Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. {ECO:0000269|PubMed:15146185, ECO:0000269|PubMed:15146186, ECO:0000269|PubMed:15318302, ECO:0000269|PubMed:20124326, ECO:0000269|PubMed:20358602, ECO:0000269|PubMed:21934712, ECO:0000269|PubMed:23254390, ECO:0000269|PubMed:25447906}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94334	0.10487	-2.44943873	1.014390186	759.33568	5.46172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	613	chr5	36876936	chr5:36876936	TC	T	100	PASS	AN=2;DP=613	GT	0/1
chr5	74011539	74011539	T	-	intronic	HEXB	.	.	.	1.49E-05	0.991564206	0.008420879	DISEASE: GM2-gangliosidosis 2 (GM2G2) [MIM:268800]: An autosomal recessive lysosomal storage disease marked by the accumulation of GM2 gangliosides in the neuronal cells. Clinically indistinguishable from GM2-gangliosidosis type 1, presenting startle reactions, early blindness, progressive motor and mental deterioration, macrocephaly and cherry-red spots on the macula. {ECO:0000269|PubMed:1531140, ECO:0000269|PubMed:1720305, ECO:0000269|PubMed:7557963, ECO:0000269|PubMed:7626071, ECO:0000269|PubMed:7633435, ECO:0000269|PubMed:8357844, ECO:0000269|PubMed:8950198, ECO:0000269|PubMed:9401004, ECO:0000269|PubMed:9694901, ECO:0000269|PubMed:9856491}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20473	0.08046	0.951720429	90.06251474	1282.40292	6.74324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	135	chr5	74011538	chr5:74011538	CT	C	74	PASS	AN=2;DP=135	GT	0/1
chr5	74011540	74011540	-	A	intronic	HEXB	.	.	.	1.49E-05	0.991564206	0.008420879	DISEASE: GM2-gangliosidosis 2 (GM2G2) [MIM:268800]: An autosomal recessive lysosomal storage disease marked by the accumulation of GM2 gangliosides in the neuronal cells. Clinically indistinguishable from GM2-gangliosidosis type 1, presenting startle reactions, early blindness, progressive motor and mental deterioration, macrocephaly and cherry-red spots on the macula. {ECO:0000269|PubMed:1531140, ECO:0000269|PubMed:1720305, ECO:0000269|PubMed:7557963, ECO:0000269|PubMed:7626071, ECO:0000269|PubMed:7633435, ECO:0000269|PubMed:8357844, ECO:0000269|PubMed:8950198, ECO:0000269|PubMed:9401004, ECO:0000269|PubMed:9694901, ECO:0000269|PubMed:9856491}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20473	0.08046	0.951720429	90.06251474	1282.40292	6.74324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.76	71	chr5	74011540	chr5:74011540	T	TA	14.76	PASS	AN=0;DP=71	GT	0/1
chr5	96314793	96314793	-	T	intronic	LNPEP	.	.	.	0.998308426	0.001691574	6.39E-11	.	0.07652	0.30451	0.181903047	66.2361406	2452.71206	9.21552	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	125	chr5	96314793	chr5:96314793	C	CT	43	PASS	AN=2;DP=125	GT	0/1
chr5	122139264	122139264	A	G	exonic	SNX2	.	nonsynonymous SNV	SNX2:NM_001278199:exon6:c.A248G:p.H83R,SNX2:NM_003100:exon6:c.A599G:p.H200R	0.997941242	0.002058746	1.25E-08	.	0.339	0.13169	-0.692458599	14.96815287	25.76147	0.83932	1.0	0.085	T	0.001	0.067	B	0.01	0.139	B	0.000	0.629	D	1.000	0.588	D	1.005	0.253	L	1.29	0.358	T	-1.11	0.383	N	0.464	0.519	-1.076	0.082	T	0.050	0.213	T	0.012	0.306	T	0.454	0.138	7.070	0.927	0.217	0.983	0.817	D	c	-0.333	-0.115	0.988	0.315	0.732	0.924	0	4.38	0.519	7.334	0.783	1.028	0.649	1.000	0.715	0.999	0.750	11.303	0.484	Phox homologous domain;Sorting nexin, N-terminal	.	.	0.5	.	56	chr5	122139264	chr5:122139264	A	G	.	PASS	AN=0;DP=56	GT	0/1
chr5	134015276	134015276	-	T	intronic	SEC24A	.	.	.	1.31E-05	0.999969557	1.73E-05	.	0.19793	0.09969	-1.058182374	7.554847841	248.85929	3.3989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	92	chr5	134015276	chr5:134015276	G	GT	85	PASS	AN=2;DP=92	GT	0/1
chr5	145890197	145890197	A	C	exonic	TCERG1	.	nonsynonymous SNV	TCERG1:NM_001040006:exon21:c.A3226C:p.T1076P,TCERG1:NM_006706:exon22:c.A3289C:p.T1097P	0.999962712	3.73E-05	1.19E-15	.	0.94723	0.23802	-0.865195027	10.79853739	89.92295	2.04005	0.008	0.614	D	0.998	0.715	D	0.934	0.652	D	0.000	0.843	D	1	0.810	D	1.355	0.339	L	1.75	0.262	T	-1.44	0.354	N	0.619	0.640	-1.026	0.218	T	0.120	0.420	T	0.023	0.466	T	3.375	0.464	22.9	0.992	0.549	0.993	0.941	D	c	0.747	0.798	1.000	0.747	0.707	0.730	0	6.16	0.993	9.230	0.944	1.199	0.960	1.000	0.715	1.000	0.888	16.806	0.855	FF domain	.	.	0.5	58	183	chr5	145890197	chr5:145890197	A	C	58	PASS	AN=2;DP=183	GT	0/1
chr5	147504305	147504305	-	T	intronic	SPINK5	.	.	.	2.12E-17	0.920781311	0.079218689	DISEASE: Netherton syndrome (NETH) [MIM:256500]: An autosomal recessive congenital ichthyosis associated with hair shaft abnormalities and anomalies of the immune system. Typical features are ichthyosis linearis circumflexa, ichthyosiform erythroderma, trichorrhexis invaginata (bamboo hair), atopic dermatitis, and hayfever. High postnatal mortality is due to failure to thrive, infections and hypernatremic dehydration. {ECO:0000269|PubMed:10835624}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2529	0.29285	2.831581484	99.08586931	18873.47781	29.29597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	264	chr5	147504305	chr5:147504305	C	CT	77	PASS	AN=2;DP=264	GT	0/1
chr5	150138378	150138378	-	C	intronic	DCTN4	.	.	.	0.953389998	0.046608916	1.09E-06	.	0.38025	0.11977	-0.512444034	21.55579146	2570.86813	9.47719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	632	chr5	150138378	chr5:150138378	G	GC	96	PASS	AN=2;DP=632	GT	0/1
chr5	156934070	156934070	G	A	exonic	ADAM19	.	synonymous SNV	ADAM19:NM_033274:exon10:c.C984T:p.V328V	4.20E-06	0.999906953	8.88E-05	.	0.71514	0.13137	0.918552705	89.5730125	5188.76456	14.82439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	120	chr5	156934070	chr5:156934070	G	A	.	PASS	AN=0;DP=120	GT	0/1
chr5	156945760	156945760	G	A	intronic	ADAM19	.	.	.	4.20E-06	0.999906953	8.88E-05	.	0.71514	0.13137	0.918552705	89.5730125	5188.76456	14.82439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	129	chr5	156945760	chr5:156945760	G	A	.	PASS	AN=0;DP=129	GT	0/1
chr5	157053271	157053271	-	T	UTR3	SOX30	NM_178424:c.*76_*77insA;NM_007017:c.*339_*340insA;NM_001308165:c.*76_*77insA	.	.	0.998986334	0.001013655	1.09E-08	.	0.27011	0.09592	1.289723716	93.85468271	1024.43935	6.15363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	216	chr5	157053271	chr5:157053271	C	CT	78	PASS	AN=2;DP=216	GT	0/1
chr5	158630629	158630629	-	T	exonic	RNF145	.	frameshift insertion	RNF145:NM_001199380:exon2:c.86dupA:p.N29Kfs*43,RNF145:NM_001199381:exon2:c.47dupA:p.N16Kfs*43,RNF145:NM_001199382:exon2:c.38dupA:p.N13Kfs*43,RNF145:NM_144726:exon2:c.80dupA:p.N27Kfs*43	0.663621979	0.336332443	4.56E-05	.	0.33859	.	-0.736552314	13.93606983	26.28405	0.85227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	378	chr5	158630629	chr5:158630629	G	GT	110	PASS	AN=2;DP=378	GT	0/1
chr5	172744196	172744196	C	-	UTR3	STC2	NM_003714:c.*654delG	.	.	0.453518118	0.540378643	0.006103239	.	0.14459	0.16191	-0.53631094	20.53550366	76.39753	1.83301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	263	chr5	172744195	chr5:172744195	TC	T	62	PASS	AN=2;DP=263	GT	0/1
chr5	178293175	178293175	-	T	intronic	ZNF354B	.	.	.	1.96E-05	0.892509081	0.107471311	.	0.16272	0.10945	0.244401822	69.50931824	62.26671	1.60991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	171	chr5	178293175	chr5:178293175	C	CT	125	PASS	AN=2;DP=171	GT	0/1
chr5	179150788	179150788	-	T	intronic	CANX	.	.	.	0.86247386	0.137522598	3.54E-06	.	0.78419	0.89499	-0.159704656	41.90846898	163.62404	2.79331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	118	chr5	179150788	chr5:179150788	G	GT	93	PASS	AN=2;DP=118	GT	0/1
chr6	7402814	7402814	T	-	intronic	RIOK1	.	.	.	8.14E-07	0.909984901	0.090014285	.	0.07427	0.09451	0.778977686	87.21396556	153.59995	2.71046	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	195	chr6	7402813	chr6:7402813	CT	C	83	PASS	AN=2;DP=195	GT	0/1
chr6	12037946	12037946	-	T	intronic	HIVEP1	.	.	.	0.999986917	1.31E-05	9.27E-17	.	0.18367	.	1.216289636	93.09389007	3060.83267	10.52275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	138	chr6	12037945	chr6:12037945	CT	CTT,C	43	PASS	AN=2;DP=138	GT	0/1
chr6	12037946	12037946	T	-	intronic	HIVEP1	.	.	.	0.999986917	1.31E-05	9.27E-17	.	0.18367	.	1.216289636	93.09389007	3060.83267	10.52275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	138	chr6	12037945	chr6:12037945	CT	CTT,C	43	PASS	AN=2;DP=138	GT	0/1
chr6	13652921	13652921	-	A	intronic	RANBP9	.	.	.	0.999958496	4.15E-05	4.55E-12	.	0.77088	0.20645	-0.756778259	13.44656759	118.2155	2.36558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	88	chr6	13652921	chr6:13652921	G	GA	61	PASS	AN=2;DP=88	GT	0/1
chr6	17779922	17779922	-	A	intronic	KIF13A	.	.	.	0.999958506	4.15E-05	5.23E-19	.	0.14914	0.13297	-0.093786226	46.49681529	493.50968	4.56777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	17.87	93	chr6	17779922	chr6:17779922	G	GA	17.87	PASS	AN=0;DP=93	GT	0/1
chr6	24666321	24666321	A	-	intronic	TDP2	.	.	.	0.000137008	0.960870954	0.038992038	.	0.82591	0.12207	1.039913547	91.25973107	2341.47191	8.96523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	188	chr6	24666320	chr6:24666320	TA	T	60	PASS	AN=2;DP=188	GT	0/1
chr6	36322471	36322471	-	A	intronic	ETV7	.	.	.	2.01E-08	0.245599352	0.754400627	.	0.70881	.	1.243805243	93.41825902	433.45398	4.34535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	131	chr6	36322471	chr6:36322471	T	TA	76	PASS	AN=2;DP=131	GT	0/1
chr6	51523718	51523718	C	G	intronic	PKHD1	.	.	.	2.89E-23	1	2.32E-11	.	0.08201	0.25544	0.37824847	75.51309271	3737.47294	11.94762	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	chr6	51523718	chr6:51523718	C	G	.	PASS	AN=0;DP=45	GT	0/1
chr6	57255016	57255016	-	C	intronic	PRIM2	.	.	.	5.15E-08	0.39171957	0.608280379	.	0.89222	0.08308	.	.	55.84911	1.50063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	46	chr6	57255016	chr6:57255016	A	AC	100	PASS	AN=2;DP=46	GT	0/1
chr6	73951959	73951959	C	T	exonic	KHDC1	.	synonymous SNV	KHDC1:NM_030568:exon3:c.G114A:p.G38G,KHDC1:NM_001251874:exon4:c.G333A:p.G111G	6.80E-05	0.49146714	0.508464847	.	0.09427	.	0.038710339	56.92380278	694.65301	5.25432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	128	chr6	73951959	chr6:73951959	C	T	72	PASS	AN=2;DP=128	GT	0/1
chr6	80194766	80194766	-	A	UTR3	LCA5	NM_181714:c.*1954_*1955insT;NM_001122769:c.*1954_*1955insT	.	.	0.004282174	0.994223193	0.001494632	DISEASE: Leber congenital amaurosis 5 (LCA5) [MIM:604537]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:17546029, ECO:0000269|PubMed:18000884, ECO:0000269|PubMed:18334959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1667	0.11088	-0.130380821	44.03161123	3626.18224	11.68454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	19	chr6	80194766	chr6:80194766	G	GA	42	PASS	AN=2;DP=19	GT	0/1
chr6	114292040	114292040	T	-	exonic	HDAC2	.	frameshift deletion	HDAC2:NM_001527:exon1:c.33delA:p.V12Sfs*18	0.999390588	0.000609409	3.17E-09	.	0.95245	0.84052	-0.119252484	44.53880632	722.29744	5.33473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	387	chr6	114292039	chr6:114292039	CT	C	68	PASS	AN=2;DP=387	GT	0/1
chr6	158049415	158049415	C	G	exonic	ZDHHC14	.	nonsynonymous SNV	ZDHHC14:NM_024630:exon4:c.C600G:p.N200K,ZDHHC14:NM_153746:exon4:c.C600G:p.N200K	0.982366558	0.01763106	2.38E-06	.	.	0.10652	0.350995466	74.37485256	67.03988	1.69272	0.001	0.912	D	1.0	0.899	D	0.995	0.971	D	0.000	0.843	D	1	0.810	D	3.71	0.948	H	1.72	0.266	T	-5.84	0.884	D	0.488	0.535	-0.374	0.729	T	0.221	0.584	T	0.072	0.714	D	6.510	0.897	31	0.998	0.908	0.972	0.734	D	c	0.872	0.798	1.000	0.747	0.706	0.609	0	5.56	0.836	5.746	0.681	0.935	0.490	1.000	0.715	1.000	0.888	19.535	0.952	Zinc finger, DHHC-type, palmitoyltransferase	.	.	0.5	108	152	chr6	158049415	chr6:158049415	C	G	108	PASS	AN=2;DP=152	GT	0/1
chr6	161121626	161121626	C	T	intergenic	LPA;PLG	dist=34219;dist=1599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	343	chr6	161121626	chr6:161121626	C	T	90	PASS	AN=2;DP=343	GT	0/1
chr7	6470059	6470059	-	T	intronic	DAGLB	.	.	.	1.65E-06	0.962595118	0.037403231	.	0.12004	0.10395	0.033039107	55.85633404	760.30438	5.46562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	95	chr7	6470058	chr7:6470058	CT	CTT,C	64	PASS	AN=2;DP=95	GT	0/1
chr7	6470059	6470059	T	-	intronic	DAGLB	.	.	.	1.65E-06	0.962595118	0.037403231	.	0.12004	0.10395	0.033039107	55.85633404	760.30438	5.46562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	95	chr7	6470058	chr7:6470058	CT	CTT,C	64	PASS	AN=2;DP=95	GT	0/1
chr7	63673455	63673455	-	T	intronic	ZNF735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	152	chr7	63673455	chr7:63673455	C	CT	83	PASS	AN=2;DP=152	GT	0/1
chr7	64838858	64838873	CAAGAACTTGGAGGTT	-	UTR5	ZNF92	NM_001287534:c.-24398_-24383del-;NM_001287532:c.-53_-38del-;NM_152626:c.-53_-38del-;NM_001287533:c.-24398_-24383del-;NM_007139:c.-14938_-14923del-	.	.	9.99E-08	0.176620877	0.823379023	.	0.1653	0.0977	0.174625237	65.9648502	1743.34182	7.7071	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	734	chr7	64838857	chr7:64838857	GCAAGAACTTGGAGGTT	G	105	PASS	AN=2;DP=734	GT	0/1
chr7	66703238	66703238	-	T	intronic	TYW1	.	.	.	0.000457249	0.999231545	0.000311206	.	0.12951	0.08688	-1.173870472	5.99197924	2883.67083	10.17398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	113	chr7	66703238	chr7:66703238	A	AT	72	PASS	AN=2;DP=113	GT	0/1
chr7	76991911	76991911	T	-	exonic	GSAP	.	frameshift deletion	GSAP:NM_001350900:exon11:c.293delA:p.Y98Sfs*20,GSAP:NM_001350901:exon11:c.293delA:p.Y98Sfs*20,GSAP:NM_001350898:exon12:c.881delA:p.Y294Sfs*20,GSAP:NM_001350896:exon13:c.938delA:p.Y313Sfs*20,GSAP:NM_001350897:exon13:c.938delA:p.Y313Sfs*20,GSAP:NM_001350899:exon13:c.938delA:p.Y313Sfs*20,GSAP:NM_017439:exon13:c.938delA:p.Y313Sfs*20	3.60E-16	0.241435267	0.758564733	.	.	.	0.268267497	70.64166077	2346.20682	8.97223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	34	chr7	76991910	chr7:76991910	GT	G	87	PASS	AN=2;DP=34	GT	0/1
chr7	84594250	84594253	AAGG	-	intergenic	LOC101927378;SEMA3D	dist=380616;dist=30619	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	189	chr7	84594249	chr7:84594249	AAAGG	A	80	PASS	AN=2;DP=189	GT	0/1
chr7	87323220	87323220	A	T	intronic	ABCB1;RUNDC3B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	112	chr7	87323220	chr7:87323220	A	T	59	PASS	AN=2;DP=112	GT	0/1
chr7	94042504	94042504	-	T	intronic	COL1A2	.	.	.	0.999754944	0.000245056	9.66E-16	DISEASE: Ehlers-Danlos syndrome 7B (EDS7B) [MIM:130060]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations. {ECO:0000269|PubMed:1577745, ECO:0000269|PubMed:2394758, ECO:0000269|PubMed:3680255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta. {ECO:0000269|PubMed:16705691, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. {ECO:0000269|PubMed:10627137, ECO:0000269|PubMed:1284475, ECO:0000269|PubMed:1339453, ECO:0000269|PubMed:1385413, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1874719, ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:2777764, ECO:0000269|PubMed:2914942, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:7891382, ECO:0000269|PubMed:7906591, ECO:0000269|PubMed:7959683, ECO:0000269|PubMed:8182080, ECO:0000269|Ref.33}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form (EDSCV) [MIM:225320]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. In addition to joint laxity, skin hyperextensibility and friability, and abnormal scar formation, patients have mitral valve prolapse and insufficiency, mitral regurgitation, and aortic insufficiency. {ECO:0000269|PubMed:16816023}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:10408781, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:7520724, ECO:0000269|PubMed:7720740, ECO:0000269|PubMed:7749416, ECO:0000269|PubMed:7860070, ECO:0000269|PubMed:7881420, ECO:0000269|PubMed:8081394, ECO:0000269|PubMed:8444468, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8723681, ECO:0000269|PubMed:8800927, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:1642148, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:2052622, ECO:0000269|PubMed:2064612, ECO:0000269|PubMed:2897363, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8401517, ECO:0000269|PubMed:8800927}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving COL1A2 may be a cause of lipoblastomas, which are benign tumors resulting from transformation of adipocytes, usually diagnosed in children. Translocation t(7;8)(p22;q13) with PLAG1.; 	0.99859	.	-1.144569759	6.363529134	161.91131	2.78024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	172	chr7	94042504	chr7:94042504	C	CT	76	PASS	AN=2;DP=172	GT	0/1
chr7	94285912	94285912	-	T	intronic	PEG10	.	.	.	0.894178858	0.10478651	0.001034632	.	0.70725	0.10969	-0.273576253	33.97027601	11.52995	0.4171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	209	chr7	94285912	chr7:94285912	G	GT	115	PASS	AN=2;DP=209	GT	0/1
chr7	99971918	99971918	A	G	exonic	PILRA	.	nonsynonymous SNV	PILRA:NM_013439:exon2:c.A316G:p.K106E,PILRA:NM_178272:exon2:c.A316G:p.K106E,PILRA:NM_178273:exon2:c.A316G:p.K106E	2.14E-08	0.139762091	0.860237888	.	0.05578	.	0.685332364	85.09672092	24.52952	0.80605	0.688	0.065	T	0.3	0.308	B	0.065	0.259	B	0.028	0.017	N	1	0.090	N	0.805	0.203	L	2.0	0.215	T	-1.04	0.277	N	0.061	0.047	-1.056	0.128	T	0.024	0.102	T	0.005	0.122	T	-2.340	0.004	0.001	0.583	0.058	0.004	0.022	N	c	-1.585	-1.700	1.000	0.747	0.657	0.484	0	-6.76	0.016	-0.190	0.095	-0.632	0.042	0.000	0.063	0.043	0.159	5.144	0.142	Immunoglobulin V-set domain|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	91	231	chr7	99971918	chr7:99971918	A	G	91	PASS	AN=2;DP=231	GT	0/1
chr7	131113756	131113756	-	T	intronic	MKLN1	.	.	.	0.999577505	0.000422495	5.31E-11	.	0.35761	0.14611	-0.427900189	25.14744043	19.26303	0.66403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	83	chr7	131113756	chr7:131113756	C	CT	83	PASS	AN=2;DP=83	GT	0/1
chr7	149990333	149990333	A	T	intronic	ACTR3C	.	.	.	0.001231511	0.635607514	0.363160974	.	.	.	0.479642105	78.95140363	1248.01469	6.67146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	27	chr7	149990333	chr7:149990333	A	T	71	PASS	AN=2;DP=27	GT	0/1
chr8	12384196	12384196	-	T	ncRNA_intronic	LOC100506990	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	732	chr8	12384196	chr8:12384196	G	GT	96	PASS	AN=2;DP=732	GT	0/1
chr8	21550683	21550683	-	T	UTR3	GFRA2	NM_001495:c.*106_*107insA;NM_001165038:c.*106_*107insA;NM_001165039:c.*106_*107insA	.	.	0.337127995	0.648312857	0.014559149	.	0.31812	0.14483	.	.	4026.41733	12.57097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	216	chr8	21550683	chr8:21550683	A	AT	62	PASS	AN=2;DP=216	GT	0/1
chr8	25766097	25766097	-	T	intronic	EBF2	.	.	.	0.97196579	0.028033904	3.06E-07	.	.	.	-0.624497208	17.16206653	336.08683	3.8943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	40	chr8	25766097	chr8:25766097	A	AT	110	PASS	AN=2;DP=40	GT	0/1
chr8	37968324	37968324	T	G	exonic	ASH2L	.	nonsynonymous SNV	ASH2L:NM_001282272:exon4:c.T141G:p.H47Q,ASH2L:NM_001105214:exon5:c.T276G:p.H92Q,ASH2L:NM_001261832:exon5:c.T276G:p.H92Q,ASH2L:NM_004674:exon5:c.T558G:p.H186Q	0.995792116	0.00420787	1.44E-08	.	0.14146	0.11705	-0.26993514	34.59542345	107.32611	2.24775	0.68	0.682	T	0.012	0.561	B	0.006	0.572	B	0.000	0.843	D	1	0.810	D	1.59	0.404	L	1.87	0.241	T	-0.4	0.247	N	0.736	0.790	-1.071	0.091	T	0.081	0.320	T	0.019	0.414	T	1.274	0.218	12.14	0.847	0.150	0.915	0.533	D	c	-0.183	-0.140	0.992	0.325	0.719	0.830	0	2.34	0.279	0.209	0.171	0.890	0.394	0.991	0.370	0.994	0.587	8.795	0.338	.	.	.	0.5	74	80	chr8	37968324	chr8:37968324	T	G	74	PASS	AN=2;DP=80	GT	0/1
chr8	39634686	39634686	A	-	intronic	ADAM2	.	.	.	7.21E-14	0.114372503	0.885627497	.	0.24145	0.11638	0.870809653	88.86529842	460.37141	4.45049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	29	chr8	39634685	chr8:39634685	GA	G	44	PASS	AN=2;DP=29	GT	0/1
chr8	68140383	68140383	-	T	intronic	ARFGEF1	.	.	.	0.999999909	9.06E-08	1.03E-22	.	0.89864	0.2827	-1.745389579	2.37084218	294.25109	3.66374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	175	chr8	68140383	chr8:68140383	A	AT	64	PASS	AN=2;DP=175	GT	0/1
chr8	79672953	79672953	A	G	intronic	IL7	.	.	.	0.879873742	0.118691896	0.001434362	.	0.10724	0.49624	0.21326276	67.71644256	134.94454	2.52665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	270	chr8	79672953	chr8:79672953	A	G	127	PASS	AN=2;DP=270	GT	0/1
chr8	120800692	120800692	-	A	intronic	TAF2	.	.	.	0.56608706	0.433912904	3.61E-08	.	0.41383	0.119	-0.042196577	50.49539986	1043.41092	6.19966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	74	chr8	120800692	chr8:120800692	T	TA	61	PASS	AN=2;DP=74	GT	0/1
chr8	141754827	141754827	G	C	exonic	PTK2	.	nonsynonymous SNV	PTK2:NM_001199649:exon19:c.C1558G:p.L520V,PTK2:NM_001316342:exon19:c.C1258G:p.L420V,PTK2:NM_005607:exon19:c.C1624G:p.L542V,PTK2:NM_153831:exon19:c.C1558G:p.L520V	0.999992958	7.04E-06	1.01E-16	DISEASE: Note=Aberrant PTK2/FAK1 expression may play a role in cancer cell proliferation, migration and invasion, in tumor formation and metastasis. PTK2/FAK1 overexpression is seen in many types of cancer.; 	0.86876	.	-1.506435464	3.544468035	55.1779	1.48998	0.406	0.377	T	0.977	0.566	D	0.843	0.585	P	0.000	0.843	D	1.000	0.513	D	0.11	0.085	N	-0.0	0.626	T	-2.06	0.539	N	0.692	0.697	-1.056	0.128	T	0.103	0.379	T	0.017	0.391	T	1.949	0.295	15.89	0.987	0.450	0.961	0.674	D	c	-0.024	0.056	0.072	0.156	0.707	0.730	0	2.58	0.299	1.545	0.355	0.998	0.613	0.988	0.363	0.997	0.653	10.713	0.450	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain	.	.	0.5	67	47	chr8	141754827	chr8:141754827	G	C	67	PASS	AN=2;DP=47	GT	0/1
chr9	27011885	27011885	-	T	intronic	IFT74	.	.	.	9.27E-06	0.999295023	0.000695708	.	0.28662	0.08508	1.199707453	92.98183534	3982.59417	12.48355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	85	chr9	27011885	chr9:27011885	C	CT	75	PASS	AN=2;DP=85	GT	0/1
chr9	71852904	71852904	-	T	intronic	TJP2	.	.	.	6.24E-07	0.999943176	5.62E-05	DISEASE: Cholestasis, progressive familial intrahepatic, 4 (PFIC4) [MIM:615878]: A disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood. {ECO:0000269|PubMed:24614073}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30256	0.24991	1.458702267	95.175749	1977.00591	8.193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	145	chr9	71852904	chr9:71852904	G	GT	71	PASS	AN=2;DP=145	GT	0/1
chr9	79318365	79318365	C	A	exonic	PRUNE2	.	stopgain	PRUNE2:NM_001308047:exon9:c.G8164T:p.E2722X,PRUNE2:NM_001308048:exon9:c.G8164T:p.E2722X,PRUNE2:NM_015225:exon9:c.G8164T:p.E2722X	3.68E-12	0.999991467	8.53E-06	.	0.07279	0.07799	2.779178029	99.02689314	10480.06134	22.38246	.	.	.	.	.	.	.	.	.	0.001	0.407	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.257	0.996	45	0.997	0.791	0.926	0.558	D	c	0.998	0.846	1.000	0.747	0.615	0.372	0	5.71	0.890	1.226	0.320	0.892	0.403	1.000	0.715	1.000	0.888	13.305	0.596	.	.	.	0.5	66	202	chr9	79318365	chr9:79318365	C	A	66	PASS	AN=2;DP=202	GT	0/1
chr9	80646047	80646047	G	A	exonic	GNAQ	.	synonymous SNV	GNAQ:NM_002072:exon1:c.C105T:p.D35D	0.984390021	0.015608215	1.76E-06	DISEASE: Capillary malformations, congenital (CMC) [MIM:163000]: A form of vascular malformations that are present from birth, tend to grow with the individual, do not regress spontaneously, and show normal rates of endothelial cell turnover. Capillary malformations are distinct from capillary hemangiomas, which are highly proliferative lesions that appear shortly after birth and show rapid growth, slow involution, and endothelial hypercellularity. {ECO:0000269|PubMed:23656586}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Sturge-Weber syndrome (SWS) [MIM:185300]: A syndrome characterized by an intracranial vascular anomaly, leptomeningeal angiomatosis, most often involving the occipital and posterior parietal lobes. The most common features are facial cutaneous vascular malformations (port-wine stains), seizures, and glaucoma. Stasis results in ischemia underlying the leptomeningeal angiomatosis, leading to calcification and laminar cortical necrosis. The clinical course is highly variable and some children experience intractable seizures, mental retardation, and recurrent stroke-like episodes. {ECO:0000269|PubMed:23656586}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.49774	0.43956	-0.251530012	35.42108988	4.88397	0.18068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	494	chr9	80646047	chr9:80646047	G	A	130	PASS	AN=2;DP=494	GT	0/1
chr9	100618882	100618900	GGTTCAGTCCAAATGGGGA	-	UTR3	FOXE1	NM_004473:c.*1564_*1582delGGTTCAGTCCAAATGGGGA	.	.	.	.	.	DISEASE: Bamforth-Lazarus syndrome (BLS) [MIM:241850]: A disease characterized by thyroid agenesis, cleft palate and choanal atresia. {ECO:0000269|PubMed:12165566, ECO:0000269|PubMed:9697705}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.10592	.	.	82.34677	1.92681	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	69	chr9	100618881	chr9:100618881	TGGTTCAGTCCAAATGGGGA	T	94	PASS	AN=2;DP=69	GT	0/1
chr9	112225553	112225553	-	A	intronic	PTPN3	.	.	.	0.000188228	0.999811394	3.78E-07	.	0.33179	0.60913	-1.16661987	6.074545883	3579.8361	11.56829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	92	chr9	112225552	chr9:112225552	TA	TAA,T	53	PASS	AN=2;DP=92	GT	0/1
chr9	112225553	112225553	A	-	intronic	PTPN3	.	.	.	0.000188228	0.999811394	3.78E-07	.	0.33179	0.60913	-1.16661987	6.074545883	3579.8361	11.56829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	92	chr9	112225552	chr9:112225552	TA	TAA,T	53	PASS	AN=2;DP=92	GT	0/1
chr9	116172488	116172488	-	C	intronic	POLE3	.	.	.	0.077745399	0.751043147	0.171211454	.	0.34686	0.24974	-0.119252484	44.53880632	8.01565	0.29467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	1432	chr9	116172488	chr9:116172488	G	GC	93	PASS	AN=2;DP=1432	GT	0/1
chr9	132595850	132595850	T	-	intronic	C9orf78	.	.	.	0.117679602	0.876685775	0.005634624	.	0.16424	0.11262	-0.141298762	42.87567823	13.49973	0.49056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	118	chr9	132595849	chr9:132595849	AT	A	55	PASS	AN=2;DP=118	GT	0/1
chr10	32096466	32096466	A	-	UTR3	ARHGAP12	NM_001270696:c.*120delT;NM_001270699:c.*120delT;NM_018287:c.*120delT;NM_001270695:c.*120delT;NM_001270697:c.*120delT;NM_001270698:c.*120delT	.	.	0.002317772	0.997652082	3.01E-05	.	0.59182	0.1351	-0.819281839	11.93677754	2139.4248	8.5073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	130	chr10	32096465	chr10:32096465	CA	C	66	PASS	AN=2;DP=130	GT	0/1
chr10	70182521	70182521	A	-	exonic	DNA2	.	frameshift deletion	DNA2:NM_001080449:exon15:c.2335delT:p.S779Hfs*5	1.95E-08	0.991999565	0.008000415	DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6 (PEOA6) [MIM:615156]: A disorder characterized by muscle weakness, mainly affecting the lower limbs, external ophthalmoplegia, exercise intolerance, and mitochondrial DNA deletions on muscle biopsy. Symptoms may appear in childhood or adulthood and show slow progression. {ECO:0000269|PubMed:23352259}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Seckel syndrome 8 (SCKL8) [MIM:615807]: A rare autosomal recessive disorder characterized by proportionate dwarfism of prenatal onset associated with low birth weight, growth retardation, severe microcephaly with a bird-headed like appearance, and mental retardation. {ECO:0000269|PubMed:24389050}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.62197	.	.	.	1134.53366	6.42769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	159	chr10	70182520	chr10:70182520	GA	G	67	PASS	AN=2;DP=159	GT	0/1
chr10	94429247	94429247	-	T	intergenic	KIF11;HHEX	dist=14095;dist=20434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	132	chr10	94429247	chr10:94429247	G	GT	60	PASS	AN=2;DP=132	GT	0/1
chr10	118615126	118615126	T	C	intronic	ENO4	.	.	.	.	.	.	.	.	.	.	.	139.77329	2.5778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	chr10	118615126	chr10:118615126	T	C	.	PASS	AN=0;DP=59	GT	0/1
chr10	124359956	124359956	C	T	intronic	DMBT1	.	.	.	7.36E-32	0.326788431	0.673211569	DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. Note=The gene represented in this entry is involved in disease pathogenesis. Homozygous deletions may be the predominant mechanism of DMBT1 inactivation playing a role in carcinogenesis. DMBT1 is deleted in medulloblastoma and glioblastoma cell lines; point mutations have also been reported in patients with glioma. A loss or reduction of DMBT1 expression has been seen in esophageal, gastric, lung and colorectal carcinomas as well.; 	0.25445	.	4.221416241	99.71691437	3210.34948	10.79937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	361	chr10	124359956	chr10:124359956	C	T	83	PASS	AN=2;DP=361	GT	0/1
chr10	127585212	127585212	A	T	exonic	FANK1	.	nonsynonymous SNV	FANK1:NM_001350939:exon1:c.A1T:p.M1L,FANK1:NM_145235:exon1:c.A1T:p.M1L	0.000115654	0.951345271	0.048539075	.	0.24852	0.09413	1.642526957	96.14885586	280.30409	3.588	0.109	0.292	T	0.0	0.067	B	0.0	0.063	B	.	.	.	1	0.810	D	.	.	.	1.25	0.365	T	-0.25	0.110	N	0.827	0.815	-1.086	0.063	T	0.052	0.223	T	.	.	.	1.357	0.227	12.56	0.817	0.134	0.027	0.073	N	c	-0.487	-0.442	1.000	0.747	0.005	0.000	3	2.62	0.302	0.546	0.228	0.884	0.388	0.576	0.273	0.640	0.296	7.116	0.244	.	.	.	0.5	95	344	chr10	127585212	chr10:127585212	A	T	95	PASS	AN=2;DP=344	GT	0/1
chr11	2938242	2938242	-	AGACAGGGAAGGTGCTAGGAGGGGAGGCCT	intronic	SLC22A18	.	.	.	0.001923068	0.90615362	0.091923312	DISEASE: Rhabdomyosarcoma, embryonal, 1 (RMSE1) [MIM:268210]: A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.11404	.	1.245625743	93.42415664	1793.90512	7.81719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	105	chr11	2938242	chr11:2938242	C	CAGACAGGGAAGGTGCTAGGAGGGGAGGCCT,CAGACAGGGAAGGCGTTAGGAGGGGAGGCCT	110	PASS	AN=2;DP=105	GT	0/1
chr11	2938242	2938242	-	AGACAGGGAAGGCGTTAGGAGGGGAGGCCT	intronic	SLC22A18	.	.	.	0.001923068	0.90615362	0.091923312	DISEASE: Rhabdomyosarcoma, embryonal, 1 (RMSE1) [MIM:268210]: A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.11404	.	1.245625743	93.42415664	1793.90512	7.81719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	105	chr11	2938242	chr11:2938242	C	CAGACAGGGAAGGTGCTAGGAGGGGAGGCCT,CAGACAGGGAAGGCGTTAGGAGGGGAGGCCT	110	PASS	AN=2;DP=105	GT	0/1
chr11	4827273	4827273	A	-	intergenic	OR52R1;OR51F2	dist=1663;dist=15343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	35	chr11	4827272	chr11:4827272	GA	G	75	PASS	AN=2;DP=35	GT	0/1
chr11	17526255	17526255	A	-	intronic	USH1C	.	.	.	2.72E-12	0.964484478	0.035515522	DISEASE: Usher syndrome 1C (USH1C) [MIM:276904]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:10973247}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 18A (DFNB18A) [MIM:602092]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12107438}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07835	0.169	-0.40608828	25.86694975	3991.78955	12.49143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	164	chr11	17526254	chr11:17526254	GA	G,GAA	106	PASS	AN=2;DP=164	GT	0/1
chr11	17526255	17526255	-	A	intronic	USH1C	.	.	.	2.72E-12	0.964484478	0.035515522	DISEASE: Usher syndrome 1C (USH1C) [MIM:276904]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:10973247}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 18A (DFNB18A) [MIM:602092]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12107438}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07835	0.169	-0.40608828	25.86694975	3991.78955	12.49143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	164	chr11	17526254	chr11:17526254	GA	G,GAA	106	PASS	AN=2;DP=164	GT	0/1
chr11	18427177	18427177	G	C	intronic	LDHA	.	.	.	0.05865759	0.923941779	0.01740063	DISEASE: Glycogen storage disease 11 (GSD11) [MIM:612933]: A metabolic disorder that results in exertional myoglobinuria, pain, cramps and easy fatigue. {ECO:0000269|PubMed:2334430}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43011	0.85387	-0.404032746	26.53338051	41.17522	1.20476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	119	chr11	18427177	chr11:18427177	G	C	102	PASS	AN=2;DP=119	GT	0/1
chr11	35747672	35747672	A	G	exonic	TRIM44	.	synonymous SNV	TRIM44:NM_017583:exon3:c.A948G:p.Q316Q	0.163653747	0.82154148	0.014804773	.	0.5824	0.14627	-0.293801652	32.93819297	23.99448	0.78977	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	78	chr11	35747672	chr11:35747672	A	G	81	PASS	AN=2;DP=78	GT	0/1
chr11	58331615	58331615	-	A	intronic	LPXN	.	.	.	0.017200443	0.960285294	0.022514263	.	0.39737	0.134	0.018483465	55.44939844	220.53951	3.21071	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	160	chr11	58331615	chr11:58331615	G	GA	54	PASS	AN=2;DP=160	GT	0/1
chr11	66512290	66512290	-	GGCGGC	exonic	C11orf80	.	nonframeshift insertion	C11orf80:NM_024650:exon1:c.77_78insGGCGGC:p.A34_G35insAA	0.008462596	0.978338462	0.013198942	.	0.03682	.	0.106667882	61.73036093	116.69248	2.34991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	64	chr11	66512290	chr11:66512290	G	GGGCGGC	112	PASS	AN=2;DP=64	GT	0/1
chr11	75511966	75511966	C	T	UTR3	DGAT2	NM_001253891:c.*413C>T;NM_032564:c.*413C>T	.	.	7.51E-08	0.464501216	0.535498709	.	0.13912	0.1376	0.350995466	74.37485256	327.81893	3.84936	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	124	chr11	75511966	chr11:75511966	C	T	80	PASS	AN=2;DP=124	GT	0/1
chr11	89592603	89592603	T	-	ncRNA_intronic	TRIM51EP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	397	chr11	89592602	chr11:89592602	AT	A	54	PASS	AN=2;DP=397	GT	0/1
chr11	100864088	100864088	T	A	UTR3	TMEM133	NM_032021:c.*659T>A	.	.	0.025317131	0.558322413	0.416360457	.	0.06337	.	0.080983847	59.76055674	196.60872	3.03256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	chr11	100864088	chr11:100864088	T	A	.	PASS	AN=0;DP=93	GT	0/1
chr11	104869776	104869776	T	-	intronic	CASP5	.	.	.	8.11E-09	0.273167235	0.726832757	.	0.1193	0.11456	1.199707453	92.98183534	431.34997	4.33449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	101	chr11	104869775	chr11:104869775	CT	C	59	PASS	AN=2;DP=101	GT	0/1
chr11	125505377	125505377	-	A	exonic	CHEK1	.	frameshift insertion	CHEK1:NM_001330427:exon6:c.716dupA:p.T242Nfs*18,CHEK1:NM_001330428:exon6:c.386dupA:p.T132Nfs*18,CHEK1:NM_001114121:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001114122:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001244846:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001274:exon7:c.668dupA:p.T226Nfs*18	0.00024911	0.982312119	0.017438771	.	0.99413	0.5268	-0.315847836	31.68789809	581.70191	4.88824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	216	chr11	125505377	chr11:125505377	G	GA	60	PASS	AN=2;DP=216	GT	0/1
chr12	11083284	11083284	A	C	exonic	PRH2	.	nonsynonymous SNV	PRH2:NM_001110213:exon3:c.A124C:p.I42L	0.595625943	0.394875767	0.00949829	.	.	.	0.747842143	86.47676339	51.88257	1.4229	0.532	0.070	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	-1.1	0.010	N	2.36	0.161	T	0.05	0.064	N	0.2	0.245	-0.945	0.418	T	0.018	0.076	T	0.002	0.026	T	-3.060	0.001	0.001	0.216	0.008	0.000	0.003	N	c	-2.122	-2.199	0.848	0.250	0.554	0.246	0	-1.81	0.074	-1.135	0.033	-2.478	0.003	0.000	0.063	0.000	0.016	3.420	0.069	.	.	.	0.5	76	300	chr12	11083284	chr12:11083284	A	C	76	PASS	AN=2;DP=300	GT	0/1
chr12	11461742	11461742	C	T	exonic	PRB4	.	nonsynonymous SNV	PRB4:NM_001261399:exon3:c.G175A:p.G59R,PRB4:NM_002723:exon3:c.G175A:p.G59R	8.85E-08	0.165369218	0.834630694	.	.	.	1.352234299	94.36777542	885.28057	5.79602	0.049	0.398	D	0.006	0.126	B	0.002	0.063	B	.	.	.	1	0.090	N	.	.	.	3.54	0.048	T	-0.06	0.799	N	0.142	0.320	-0.958	0.395	T	0.017	0.069	T	.	.	.	-0.012	0.092	2.468	0.344	0.021	0.001	0.006	N	c	-1.276	-1.462	0.000	0.012	0.554	0.246	0	-1.91	0.072	-0.312	0.081	0.304	0.270	0.014	0.188	0.002	0.062	2.567	0.045	.	.	.	0.5	91	405	chr12	11461742	chr12:11461742	C	T	91	PASS	AN=2;DP=405	GT	0/1
chr12	19410474	19410474	-	T	intronic	PLEKHA5	.	.	.	0.999999408	5.92E-07	1.20E-18	.	0.15553	0.09677	-0.418800956	25.79028073	470.79608	4.49027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.44	67	chr12	19410474	chr12:19410474	A	AT	10.44	PASS	AN=0;DP=67	GT	0/1
chr12	27648786	27648786	A	G	exonic	SMCO2	.	synonymous SNV	SMCO2:NM_001145010:exon8:c.A831G:p.A277A	.	.	.	.	.	.	0.881944684	89.02453409	398.02888	4.19168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	29	chr12	27648786	chr12:27648786	A	G	107	PASS	AN=2;DP=29	GT	1/0
chr12	29812859	29812859	A	T	intronic	TMTC1	.	.	.	3.06E-07	0.996221773	0.003777921	.	0.33022	0.13818	-0.418800956	25.79028073	1433.09079	7.06654	0.998	0.019	T	0.998	0.715	D	0.991	0.782	D	.	.	.	0.992	0.810	D	.	.	.	0.91	0.449	T	-0.81	0.223	N	0.309	0.465	-0.613	0.643	T	0.242	0.611	T	0.132	0.815	D	3.177	0.441	22.7	0.992	0.536	0.957	0.657	D	c	0.642	0.647	1.000	0.480	0.706	0.609	0	5.4	0.779	7.390	0.789	1.088	0.866	1.000	0.715	0.998	0.697	11.814	0.513	Domain of unknown function DUF1736	.	.	0.5	86	122	chr12	29812859	chr12:29812859	A	T	86	PASS	AN=2;DP=122	GT	0/1
chr12	54676165	54676165	-	T	ncRNA_intronic	HNRNPA1P10	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	77	chr12	54676165	chr12:54676165	G	GT	84	PASS	AN=2;DP=77	GT	0/1
chr12	54763673	54763673	C	-	ncRNA_intronic	LOC102724050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	401	chr12	54763672	chr12:54763672	TC	T	65	PASS	AN=2;DP=401	GT	0/1
chr12	56294484	56294484	A	-	downstream	PYM1	dist=713	.	.	.	.	.	.	0.15471	0.12127	-0.163345027	41.24793583	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	118	chr12	56294483	chr12:56294483	GA	G	80	PASS	AN=2;DP=118	GT	0/1
chr12	57638386	57638386	T	A	exonic	STAC3	.	nonsynonymous SNV	STAC3:NM_001286257:exon6:c.A182T:p.Q61L,STAC3:NM_001286256:exon8:c.A623T:p.Q208L,STAC3:NM_145064:exon9:c.A740T:p.Q247L	0.004878302	0.989072823	0.006048875	DISEASE: Native American myopathy (NAM) [MIM:255995]: A disease characterized by congenital weakness and arthrogryposis, cleft palate, ptosis, short stature, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia provoked by anesthesia. {ECO:0000269|PubMed:23736855}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16182	0.10482	-0.137658575	43.57159707	50.70761	1.40292	0.26	0.165	T	0.01	0.144	B	0.004	0.093	B	0.104	0.197	N	0.750	0.306	N	1.15	0.294	L	1.62	0.282	T	-0.09	0.090	N	0.42	0.477	-1.018	0.244	T	0.021	0.087	T	0.008	0.226	T	2.404	0.350	18.85	0.973	0.329	0.810	0.402	D	c	-0.565	-0.295	1.000	0.500	0.706	0.609	0	3.87	0.437	0.181	0.166	0.964	0.580	0.991	0.370	1.000	0.888	6.628	0.219	SH3 domain	.	.	0.5	94	146	chr12	57638386	chr12:57638386	T	A	94	PASS	AN=2;DP=146	GT	0/1
chr12	63964641	63964641	A	-	intronic	DPY19L2	.	.	.	7.03E-05	0.999003807	0.000925899	.	0.1085	.	1.354051915	94.39726351	4007.99241	12.53898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	47	chr12	63964640	chr12:63964640	GA	G	66	PASS	AN=2;DP=47	GT	0/1
chr12	66716618	66716618	-	T	intronic	HELB	.	.	.	2.02E-13	0.201004528	0.798995472	.	0.03646	0.09863	1.076540831	91.72564284	4335.69084	13.10867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	41	chr12	66716618	chr12:66716618	G	GT	78	PASS	AN=2;DP=41	GT	0/1
chr12	68690766	68690766	A	-	intronic	MDM1	.	.	.	5.78E-08	0.961965994	0.038033948	.	0.42256	0.109	0.383960053	75.66053314	1434.83695	7.07219	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	51	chr12	68690765	chr12:68690765	TA	T	78	PASS	AN=2;DP=51	GT	0/1
chr12	72094581	72094581	T	C	intronic	TMEM19	.	.	.	0.001380694	0.866114693	0.132504613	.	0.0797	0.1104	0.350995466	74.37485256	257.67543	3.45315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	165	chr12	72094581	chr12:72094581	T	C	76	PASS	AN=2;DP=165	GT	0/1
chr12	102140524	102140524	-	A	UTR3	GNPTAB	NM_024312:c.*417_*418insT	.	.	4.23E-06	0.999977941	1.78E-05	DISEASE: Mucolipidosis type II (MLII) [MIM:252500]: Fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features, peculiar fibroblast inclusions, and no excessive mucopolysacchariduria. Congenital dislocation of the hip, thoracic deformities, hernia, and hyperplastic gums are evident soon after birth. {ECO:0000269|PubMed:16200072, ECO:0000269|PubMed:16835905, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:22495880, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:23733939, ECO:0000269|PubMed:23773965, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24798265, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]: Autosomal recessive disease of lysosomal enzyme targeting. Clinically MLIII is characterized by restricted joint mobility, skeletal dysplasia, and short stature. Mildly coarsened facial features and thickening of the skin have been described. Cardiac valvular disease and corneal clouding may also occur. Half of the reported patients show learning disabilities or mental retardation. {ECO:0000269|PubMed:16094673, ECO:0000269|PubMed:16465621, ECO:0000269|PubMed:16630736, ECO:0000269|PubMed:17034777, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:24045841, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24550498, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTAB have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.70519	0.14868	-1.366884746	4.505779665	437.11196	4.35866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	134	chr12	102140522	chr12:102140522	GAA	GAAA,G,GA	69	PASS	AN=2;DP=134	GT	0/1
chr12	102140523	102140524	AA	-	UTR3	GNPTAB	NM_024312:c.*419_*418delTT	.	.	4.23E-06	0.999977941	1.78E-05	DISEASE: Mucolipidosis type II (MLII) [MIM:252500]: Fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features, peculiar fibroblast inclusions, and no excessive mucopolysacchariduria. Congenital dislocation of the hip, thoracic deformities, hernia, and hyperplastic gums are evident soon after birth. {ECO:0000269|PubMed:16200072, ECO:0000269|PubMed:16835905, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:22495880, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:23733939, ECO:0000269|PubMed:23773965, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24798265, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]: Autosomal recessive disease of lysosomal enzyme targeting. Clinically MLIII is characterized by restricted joint mobility, skeletal dysplasia, and short stature. Mildly coarsened facial features and thickening of the skin have been described. Cardiac valvular disease and corneal clouding may also occur. Half of the reported patients show learning disabilities or mental retardation. {ECO:0000269|PubMed:16094673, ECO:0000269|PubMed:16465621, ECO:0000269|PubMed:16630736, ECO:0000269|PubMed:17034777, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:24045841, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24550498, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTAB have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.70519	0.14868	-1.366884746	4.505779665	437.11196	4.35866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	134	chr12	102140522	chr12:102140522	GAA	GAAA,G,GA	69	PASS	AN=2;DP=134	GT	0/1
chr12	102140524	102140524	A	-	UTR3	GNPTAB	NM_024312:c.*418delT	.	.	4.23E-06	0.999977941	1.78E-05	DISEASE: Mucolipidosis type II (MLII) [MIM:252500]: Fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features, peculiar fibroblast inclusions, and no excessive mucopolysacchariduria. Congenital dislocation of the hip, thoracic deformities, hernia, and hyperplastic gums are evident soon after birth. {ECO:0000269|PubMed:16200072, ECO:0000269|PubMed:16835905, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:22495880, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:23733939, ECO:0000269|PubMed:23773965, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24798265, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]: Autosomal recessive disease of lysosomal enzyme targeting. Clinically MLIII is characterized by restricted joint mobility, skeletal dysplasia, and short stature. Mildly coarsened facial features and thickening of the skin have been described. Cardiac valvular disease and corneal clouding may also occur. Half of the reported patients show learning disabilities or mental retardation. {ECO:0000269|PubMed:16094673, ECO:0000269|PubMed:16465621, ECO:0000269|PubMed:16630736, ECO:0000269|PubMed:17034777, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:24045841, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24550498, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTAB have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.70519	0.14868	-1.366884746	4.505779665	437.11196	4.35866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	134	chr12	102140522	chr12:102140522	GAA	GAAA,G,GA	69	PASS	AN=2;DP=134	GT	0/1
chr12	102301162	102301162	-	T	intronic	DRAM1	.	.	.	0.080700077	0.872050796	0.047249127	.	.	.	-0.229483771	36.86010852	8.7844	0.32424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	134	chr12	102301162	chr12:102301162	G	GT	79	PASS	AN=2;DP=134	GT	0/1
chr12	107237615	107237615	-	T	intronic	RIC8B	.	.	.	0.997486827	0.002513073	1.00E-07	.	0.53798	0.10163	-0.26993514	34.59542345	85.92104	1.97938	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	135	chr12	107237614	chr12:107237614	GT	GTT,G	95	PASS	AN=2;DP=135	GT	0/1
chr12	107237615	107237615	T	-	intronic	RIC8B	.	.	.	0.997486827	0.002513073	1.00E-07	.	0.53798	0.10163	-0.26993514	34.59542345	85.92104	1.97938	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	135	chr12	107237614	chr12:107237614	GT	GTT,G	95	PASS	AN=2;DP=135	GT	0/1
chr12	112580121	112580121	T	C	intronic	TRAFD1	.	.	.	1.83E-05	0.970465578	0.029516153	.	0.07103	0.09821	-0.201976964	38.98325077	125.66239	2.4405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	100	chr12	112580121	chr12:112580121	T	C	108	PASS	AN=2;DP=100	GT	0/1
chr12	122405912	122405912	G	T	exonic	WDR66	.	nonsynonymous SNV	WDR66:NM_001178003:exon17:c.G2608T:p.V870L,WDR66:NM_144668:exon17:c.G2608T:p.V870L	1.25E-10	0.981629339	0.018370661	.	0.16334	.	1.409099734	94.8041991	10305.45886	22.15777	0.197	0.223	T	0.518	0.356	P	0.241	0.369	B	0.000	0.473	D	0.000	0.501	P	2.215	0.627	M	0.57	0.544	T	-1.88	0.439	N	0.292	0.352	-0.911	0.467	T	0.000	0.000	T	.	.	.	2.470	0.358	19.27	0.996	0.767	0.859	0.448	D	c	0.226	0.286	1.000	0.451	0.554	0.283	0	5.19	0.713	6.424	0.731	1.048	0.713	1.000	0.715	0.964	0.448	18.708	0.916	WD40-repeat-containing domain|WD40/YVTN repeat-like-containing domain	ENSG00000158023.5|ENSG00000158023.5|ENSG00000158023.5|ENSG00000256811.1|ENSG00000158104.7|ENSG00000110801.9	Artery_Tibial|Brain_Cerebellum|Cells_Transformed_fibroblasts|Muscle_Skeletal|Muscle_Skeletal|Thyroid	0.5	91	40	chr12	122405912	chr12:122405912	G	T	91	PASS	AN=2;DP=40	GT	0/1
chr12	123214555	123214555	G	A	exonic	HCAR1	.	nonsynonymous SNV	HCAR1:NM_032554:exon1:c.C332T:p.A111V	0.14099939	0.779311972	0.079688637	.	0.13233	0.08739	-0.356299879	29.31115829	238.79328	3.33717	1.0	0.010	T	0.0	0.026	B	0.001	0.040	B	0.060	0.223	N	0.999	0.216	N	-2.69	0.000	N	1.49	0.315	T	2.42	0.003	N	0.109	0.156	-0.973	0.366	T	0.013	0.049	T	0.002	0.034	T	0.884	0.178	9.973	0.668	0.079	0.027	0.073	N	c	-1.116	-0.832	1.000	0.441	0.497	0.185	0	4.04	0.461	4.498	0.599	0.239	0.266	0.262	0.247	0.995	0.604	6.982	0.237	GPCR, rhodopsin-like, 7TM	.	.	0.5	58	216	chr12	123214555	chr12:123214555	G	A	58	PASS	AN=2;DP=216	GT	0/1
chr12	123892323	123892323	-	T	UTR3	KMT5A	NM_001324504:c.*73_*74insT;NM_001324505:c.*73_*74insT;NM_020382:c.*73_*74insT;NM_001324506:c.*73_*74insT	.	.	.	.	.	.	0.13779	0.14003	0.104848986	61.49445624	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	184	chr12	123892323	chr12:123892323	A	AT	77	PASS	AN=2;DP=184	GT	0/1
chr13	25542289	25542289	A	G	ncRNA_intronic	TPTE2P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	61	chr13	25542289	chr13:25542289	A	G	45	PASS	AN=2;DP=61	GT	0/1
chr13	32907536	32907536	T	-	intronic	BRCA2	.	.	.	2.21E-15	0.999975298	2.47E-05	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.97144	0.70346	3.731883424	99.58716678	775.59808	5.51436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	39	chr13	32907535	chr13:32907535	CT	C	77	PASS	AN=2;DP=39	GT	0/1
chr13	32911888	32911888	A	G	exonic	BRCA2	.	synonymous SNV	BRCA2:NM_000059:exon11:c.A3396G:p.K1132K	2.21E-15	0.999975298	2.47E-05	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.97144	0.70346	3.731883424	99.58716678	775.59808	5.51436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	39	chr13	32911888	chr13:32911888	A	G	95	PASS	AN=2;DP=39	GT	0/1
chr13	39435552	39435552	-	T	intronic	FREM2	.	.	.	1.25E-07	0.999999873	1.59E-09	DISEASE: Fraser syndrome (FRASS) [MIM:219000]: Multisystem malformation usually comprising cryptophthalmos, cutaneous syndactyly, ear abnormalities, renal agenesis and congenital heart defects. {ECO:0000269|PubMed:15838507}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.4129	0.11172	-0.632876892	16.77282378	10803.546	22.53898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	131	chr13	39435552	chr13:39435552	C	CT	80	PASS	AN=2;DP=131	GT	0/1
chr13	50235208	50235208	-	A	exonic	EBPL	.	stopgain	EBPL:NM_032565:exon4:c.516dupT:p.N173fs*0	0.038853333	0.838493275	0.122653391	.	0.05028	0.0701	-0.141298762	42.87567823	28.87736	0.92255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	189	chr13	50235208	chr13:50235208	T	TA	66	PASS	AN=2;DP=189	GT	0/1
chr13	98634738	98634738	T	-	intronic	IPO5	.	.	.	0.999998737	1.26E-06	3.77E-17	.	0.97485	0.23683	-0.909290275	10.03184713	1001.72714	6.09631	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	42	chr13	98634737	chr13:98634737	AT	A	76	PASS	AN=2;DP=42	GT	0/1
chr13	99461555	99461555	-	T	intronic	DOCK9	.	.	.	0.999999307	6.93E-07	2.96E-21	.	0.35485	0.10142	-2.778633322	0.672328379	918.16821	5.89066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	178	chr13	99461555	chr13:99461555	G	GT	63	PASS	AN=2;DP=178	GT	0/1
chr14	21702046	21702046	-	A	intronic	HNRNPC	.	.	.	0.985848437	0.014144716	6.85E-06	.	0.16171	0.28104	-0.075159878	47.78839349	6.88559	0.25634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	71	chr14	21702046	chr14:21702046	C	CA	52	PASS	AN=2;DP=71	GT	0/1
chr14	22771929	22771929	-	A	intergenic	OR4E1;LINC02332	dist=632697;dist=253276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	170	chr14	22771929	chr14:22771929	G	GA	69	PASS	AN=2;DP=170	GT	0/1
chr14	23528502	23528503	TC	-	exonic	ACIN1	.	frameshift deletion	ACIN1:NM_001164816:exon12:c.1699_1700del:p.E567Kfs*11,ACIN1:NM_001164817:exon13:c.1606_1607del:p.E536Kfs*11,ACIN1:NM_001164815:exon18:c.3760_3761del:p.E1254Kfs*11,ACIN1:NM_001164814:exon19:c.3841_3842del:p.E1281Kfs*11,ACIN1:NM_014977:exon19:c.3880_3881del:p.E1294Kfs*11	0.999998437	1.56E-06	2.59E-18	.	0.75733	0.42314	-0.435396074	24.70511913	7850.70685	19.11113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	136	chr14	23528501	chr14:23528501	TTC	T	91	PASS	AN=2;DP=136	GT	0/1
chr14	24475265	24475265	T	C	UTR3	DHRS4L2	NM_001193637:c.*193T>C;NM_001193636:c.*193T>C;NM_001193635:c.*193T>C;NM_198083:c.*193T>C	.	.	0.357376762	0.630130113	0.012493125	.	0.03505	0.0907	2.465816951	98.61405992	3973.73722	12.46785	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	402	chr14	24475265	chr14:24475265	T	C	118	PASS	AN=2;DP=402	GT	0/1
chr14	31575374	31575374	A	-	intronic	HECTD1	.	.	.	1	2.36E-13	1.27E-35	.	0.71166	0.10385	-2.227040428	1.332861524	686.62409	5.23205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	133	chr14	31575373	chr14:31575373	TA	T	53	PASS	AN=2;DP=133	GT	0/1
chr14	31762500	31762500	-	A	UTR3	HEATR5A	NM_015473:c.*10_*11insT	.	.	.	.	.	.	0.2293	.	.	.	4462.98132	13.39987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	35	chr14	31762500	chr14:31762500	C	CA	69	PASS	AN=2;DP=35	GT	0/1
chr14	38261457	38261457	-	T	intronic	TTC6	.	.	.	8.74E-09	0.283902582	0.716097409	.	0.06305	0.08734	.	.	3948.4689	12.42494	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	117	chr14	38261457	chr14:38261457	A	AT	64	PASS	AN=2;DP=117	GT	0/1
chr14	39597470	39597470	-	T	intronic	GEMIN2	.	.	.	0.006609197	0.97473644	0.018654363	.	0.1302	0.1438	0.016664174	55.21939137	6043.31497	16.22939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	13	chr14	39597470	chr14:39597470	C	CT	64	PASS	AN=2;DP=13	GT	0/1
chr14	51289873	51289873	G	-	ncRNA_intronic	LOC105370489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	81	chr14	51289872	chr14:51289872	TG	T	88	PASS	AN=2;DP=81	GT	0/1
chr14	72941318	72941318	-	T	intronic	RGS6	.	.	.	0.801361183	0.198636867	1.95E-06	.	0.44756	0.09798	-0.670411825	15.61689078	74.87042	1.81038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	128	chr14	72941317	chr14:72941317	GT	GTT,G	80	PASS	AN=2;DP=128	GT	0/1
chr14	72941318	72941318	T	-	intronic	RGS6	.	.	.	0.801361183	0.198636867	1.95E-06	.	0.44756	0.09798	-0.670411825	15.61689078	74.87042	1.81038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	128	chr14	72941317	chr14:72941317	GT	GTT,G	80	PASS	AN=2;DP=128	GT	0/1
chr14	81953889	81953889	-	A	intronic	SEL1L	.	.	.	0.704308255	0.295691491	2.53E-07	.	0.3657	0.18583	0.154398214	64.73814579	162.19537	2.7815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	37	chr14	81953889	chr14:81953889	G	GA	62	PASS	AN=2;DP=37	GT	0/1
chr14	93650551	93650551	T	C	exonic	MOAP1	.	nonsynonymous SNV	MOAP1:NM_022151:exon3:c.A37G:p.M13V	0.001403636	0.663920629	0.334675734	.	0.19634	0.15764	0.639420866	83.8995046	91.52402	2.05748	0.014	0.531	D	0.987	0.600	D	0.945	0.664	D	.	.	.	0.999	0.214	N	2.475	0.721	M	2.5	0.144	T	-3.44	0.674	D	0.495	0.541	-1.093	0.050	T	0.073	0.295	T	0.007	0.188	T	2.392	0.349	18.77	0.964	0.292	0.339	0.247	N	c	0.142	-0.034	1.000	0.747	0.789	0.998	0	2.26	0.273	1.397	0.339	1.060	0.767	0.957	0.332	0.005	0.090	6.767	0.226	.	.	.	0.5	58	126	chr14	93650551	chr14:93650551	T	C	58	PASS	AN=2;DP=126	GT	0/1
chr14	99637948	99637948	T	-	UTR3	BCL11B	NM_022898:c.*2540delA;NM_138576:c.*2540delA;NM_001282238:c.*2540delA;NM_001282237:c.*2540delA	.	.	0.929785242	0.070140307	7.45E-05	.	0.70076	0.16232	.	.	29.1619	0.93217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	153	chr14	99637947	chr14:99637947	AT	A	82	PASS	AN=2;DP=153	GT	0/1
chr14	102302490	102302490	-	T	intronic	PPP2R5C	.	.	.	0.997672663	0.00232732	1.68E-08	.	0.16008	0.12741	0.018483465	55.44939844	1821.40468	7.87398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	242	chr14	102302490	chr14:102302490	G	GT	128	PASS	AN=2;DP=242	GT	0/1
chr14	105418538	105418538	C	T	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.G2950A:p.V984M,AHNAK2:NM_138420:exon7:c.G3250A:p.V1084M	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	0.535	0.069	T	0.229	0.288	B	0.09	0.283	B	.	.	.	1	0.198	N	0.52	0.136	N	5.57	0.009	T	-0.62	0.183	N	0.106	0.112	-0.928	0.444	T	0.003	0.009	T	0.008	0.226	T	1.040	0.194	10.88	0.977	0.350	0.012	0.042	N	c	-1.369	-1.465	0.000	0.054	0.707	0.730	0	-1.55	0.081	-1.942	0.016	-0.014	0.131	0.000	0.063	0.033	0.150	4.125	0.095	.	.	.	0.5	85	589	chr14	105418538	chr14:105418538	C	T	85	PASS	AN=2;DP=589	GT	0/1
chr15	20084006	20084006	A	G	intergenic	NONE;CHEK2P2	dist=NONE;dist=403991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	214	chr15	20084006	chr15:20084006	A	G	132	PASS	AN=2;DP=214	GT	0/1
chr15	28419774	28419774	C	T	intronic	HERC2	.	.	.	1	3.99E-17	4.70E-51	DISEASE: Mental retardation, autosomal recessive 38 (MRT38) [MIM:615516]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT38 is characterized by global developmental delay affecting motor, speech, adaptive, and social development. Patients manifest autistic features, aggression, self-injury, impulsivity, and distractibility. {ECO:0000269|PubMed:23065719}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24532	0.21556	-5.985628431	0.047180939	2166.06955	8.56756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	422	chr15	28419774	chr15:28419774	C	T	113	PASS	AN=2;DP=422	GT	0/1
chr15	28419779	28419779	A	G	intronic	HERC2	.	.	.	1	3.99E-17	4.70E-51	DISEASE: Mental retardation, autosomal recessive 38 (MRT38) [MIM:615516]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT38 is characterized by global developmental delay affecting motor, speech, adaptive, and social development. Patients manifest autistic features, aggression, self-injury, impulsivity, and distractibility. {ECO:0000269|PubMed:23065719}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24532	0.21556	-5.985628431	0.047180939	2166.06955	8.56756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	383	chr15	28419779	chr15:28419779	A	G	123	PASS	AN=2;DP=383	GT	0/1
chr15	28878923	28878923	-	T	intergenic	HERC2P11;HERC2P9	dist=44537;dist=20665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	155	chr15	28878923	chr15:28878923	A	AT	76	PASS	AN=2;DP=155	GT	0/1
chr15	32716905	32716905	A	C	ncRNA_intronic	ULK4P1;ULK4P2;ULK4P3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	chr15	32716905	chr15:32716905	A	C	.	PASS	AN=0;DP=69	GT	0/1
chr15	33923502	33923502	-	T	intronic	RYR3	.	.	.	0.999999945	5.48E-08	8.09E-38	.	0.32508	0.17005	-5.868890763	0.058976174	4624.36471	13.6808	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	19	chr15	33923502	chr15:33923502	A	AT	44	PASS	AN=2;DP=19	GT	0/1
chr15	35385345	35385347	GGC	-	intergenic	ZNF770;ANP32AP1	dist=104848;dist=144180	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	284	chr15	35385344	chr15:35385344	AGGC	A	99	PASS	AN=2;DP=284	GT	0/1
chr15	50754454	50754454	T	-	intronic	USP8	.	.	.	0.999982629	1.74E-05	2.23E-14	.	0.21578	0.12146	0.402364592	76.45081387	805.90942	5.59333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	65	chr15	50754453	chr15:50754453	CT	C	59	PASS	AN=2;DP=65	GT	0/1
chr15	62167156	62167156	A	-	intronic	VPS13C	.	.	.	1.86E-37	0.999996999	3.00E-06	.	0.21113	0.1084	-0.811192082	12.07832036	3785.30625	12.05677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	194	chr15	62167155	chr15:62167155	CA	C	73	PASS	AN=2;DP=194	GT	0/1
chr15	75651720	75651720	G	-	exonic	MAN2C1	.	frameshift deletion	MAN2C1:NM_001256496:exon15:c.1698delC:p.T567Pfs*13,MAN2C1:NM_001256494:exon17:c.2008delC:p.H670Tfs*34,MAN2C1:NM_001256495:exon17:c.1995delC:p.T666Pfs*13,MAN2C1:NM_006715:exon17:c.1995delC:p.T666Pfs*13	2.94E-25	0.000435876	0.999564124	.	0.25399	0.26675	-0.095604385	46.20783204	574.28122	4.86436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	251	chr15	75651719	chr15:75651719	TG	T	53	PASS	AN=2;DP=251	GT	0/1
chr15	80430026	80430026	-	T	UTR3	ZFAND6	NM_001242918:c.*56_*57insT;NM_001242917:c.*56_*57insT;NM_001242912:c.*56_*57insT;NM_001242911:c.*56_*57insT;NM_019006:c.*56_*57insT;NM_001242913:c.*56_*57insT;NM_001242914:c.*56_*57insT;NM_001242916:c.*56_*57insT;NM_001242915:c.*56_*57insT;NM_001242919:c.*56_*57insT	.	.	0.218468573	0.743621706	0.037909721	.	0.59679	0.11302	0.058937498	58.26256192	29.26317	0.93658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	169	chr15	80430026	chr15:80430026	G	GT	61	PASS	AN=2;DP=169	GT	0/1
chr15	102185369	102185369	A	-	intronic	TM2D3	.	.	.	0.000338995	0.597218902	0.402442103	.	0.1174	0.11255	0.350995466	74.37485256	80.9731	1.90334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	101	chr15	102185368	chr15:102185368	TA	T,TAA	62	PASS	AN=2;DP=101	GT	0/1
chr15	102185369	102185369	-	A	intronic	TM2D3	.	.	.	0.000338995	0.597218902	0.402442103	.	0.1174	0.11255	0.350995466	74.37485256	80.9731	1.90334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	101	chr15	102185368	chr15:102185368	TA	T,TAA	62	PASS	AN=2;DP=101	GT	0/1
chr16	705131	705131	T	-	exonic	WDR90	.	frameshift deletion	WDR90:NM_145294:exon14:c.1540delT:p.F515Lfs*30	4.02E-46	1.08E-08	0.999999989	.	0.12488	.	0.973706547	90.28072659	5541.15698	15.39276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	378	chr16	705130	chr16:705130	CT	C	69	PASS	AN=2;DP=378	GT	0/1
chr16	1382898	1382898	-	A	upstream	BAIAP3	dist=708	.	.	2.21E-19	0.088488031	0.911511969	.	0.29593	0.09988	-2.150176731	1.468506723	719.07294	5.32413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	340	chr16	1382898	chr16:1382898	G	GA	72	PASS	AN=2;DP=340	GT	0/1
chr16	4013844	4013844	A	-	UTR3	ADCY9	NM_001116:c.*1932delT	.	.	0.974310442	0.025689508	4.99E-08	.	0.1617	0.17928	-1.780505741	2.282377919	630.16158	5.05923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	167	chr16	4013843	chr16:4013843	GA	G	99	PASS	AN=2;DP=167	GT	0/1
chr16	5037498	5037498	-	G	intronic	SEC14L5	.	.	.	6.57E-10	0.408296631	0.591703368	.	0.15183	.	-1.703090605	2.535975466	83.7768	1.94866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	64	chr16	5037498	chr16:5037498	T	TG	99	PASS	AN=2;DP=64	GT	0/1
chr16	18869474	18869474	-	A	intronic	SMG1	.	.	.	1	4.40E-14	1.05E-36	.	.	.	-2.975494782	0.542580797	910.18577	5.86659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	468	chr16	18869474	chr16:18869474	G	GA	60	PASS	AN=2;DP=468	GT	0/1
chr16	18872151	18872151	-	A	intronic	SMG1	.	.	.	1	4.40E-14	1.05E-36	.	.	.	-2.975494782	0.542580797	910.18577	5.86659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	376	chr16	18872151	chr16:18872151	T	TA	102	PASS	AN=2;DP=376	GT	0/1
chr16	19080213	19080213	-	A	intronic	COQ7	.	.	.	4.68E-05	0.416968957	0.582984257	.	0.15929	0.14294	-0.115612493	45.12856806	146.5872	2.6373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	469	chr16	19080213	chr16:19080213	T	TA	101	PASS	AN=2;DP=469	GT	0/1
chr16	29855814	29855814	G	C	exonic	MVP	.	nonsynonymous SNV	MVP:NM_001293204:exon10:c.G1635C:p.W545C,MVP:NM_005115:exon11:c.G1635C:p.W545C,MVP:NM_017458:exon11:c.G1635C:p.W545C	0.007448525	0.991880268	0.000671207	.	0.12911	0.21917	-0.813834387	12.05472989	340.52664	3.91613	0.018	0.506	D	1.0	0.899	D	0.992	0.790	D	0.000	0.843	D	1	0.810	D	2.825	0.825	M	0.68	0.520	T	-12.08	0.996	D	0.812	0.910	-0.404	0.719	T	0.341	0.707	T	0.056	0.667	D	6.650	0.912	32	0.991	0.532	0.989	0.890	D	c	0.902	0.876	1.000	0.747	0.732	0.924	0	5.91	0.952	8.171	0.895	1.048	0.713	1.000	0.715	1.000	0.888	17.799	0.884	Shoulder domain	.	.	0.5	101	187	chr16	29855814	chr16:29855814	G	C	101	PASS	AN=2;DP=187	GT	0/1
chr16	64294574	64294574	-	A	intergenic	NONE;CDH11	dist=NONE;dist=683083	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	53	chr16	64294574	chr16:64294574	T	TA	78	PASS	AN=2;DP=53	GT	0/1
chr16	66920308	66920308	-	T	UTR3	PDP2	NM_020786:c.*531_*532insT;NM_001329934:c.*531_*532insT;NM_001329928:c.*531_*532insT;NM_001329932:c.*531_*532insT;NM_001329929:c.*531_*532insT;NM_001329933:c.*531_*532insT;NM_001329931:c.*531_*532insT;NM_001329930:c.*531_*532insT	.	.	1.86E-05	0.45419908	0.545782308	.	.	.	-0.933156985	9.54824251	36.00648	1.08197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	97	chr16	66920308	chr16:66920308	C	CT	53	PASS	AN=2;DP=97	GT	0/1
chr16	69499982	69499982	T	-	UTR3	CYB5B	NM_030579:c.*3559delT	.	.	0.25957799	0.713647973	0.026774037	.	0.23716	0.10842	-0.207437529	38.2814343	80.36516	1.8944	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	116	chr16	69499981	chr16:69499981	CT	C	76	PASS	AN=2;DP=116	GT	0/1
chr16	70165914	70165914	T	C	intronic	PDPR	.	.	.	4.85E-08	0.989391133	0.010608819	.	.	0.11815	0.874458024	88.88888889	1513.23821	7.22888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	135	chr16	70165914	chr16:70165914	T	C	.	PASS	AN=0;DP=135	GT	0/1
chr16	71887095	71887095	C	T	UTR3	ATXN1L	NM_001137675:c.*1382C>T	.	.	.	.	.	.	.	.	0.637604436	83.77565464	1685.42189	7.56537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	122	chr16	71887095	chr16:71887095	C	T	90	PASS	AN=2;DP=122	GT	0/1
chr16	89804335	89804336	CT	-	UTR3	FANCA	NM_001286167:c.*771_*770delAG;NM_000135:c.*674_*673delAG	.	.	2.08E-34	0.000122619	0.999877381	DISEASE: Fanconi anemia, complementation group A (FANCA) [MIM:227650]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:10094191, ECO:0000269|PubMed:10210316, ECO:0000269|PubMed:10521298, ECO:0000269|PubMed:10807541, ECO:0000269|PubMed:11091222, ECO:0000269|PubMed:17924555, ECO:0000269|PubMed:9371798, ECO:0000269|PubMed:9399890, ECO:0000269|PubMed:9929978}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23385	0.24341	-0.101294944	45.66525124	1788.01434	7.80511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	499	chr16	89804334	chr16:89804334	CCT	C	87	PASS	AN=2;DP=499	GT	0/1
chr16	89839766	89839766	G	C	exonic	FANCA	.	nonsynonymous SNV	FANCA:NM_000135:exon22:c.C1927G:p.P643A,FANCA:NM_001286167:exon22:c.C1927G:p.P643A	2.08E-34	0.000122619	0.999877381	DISEASE: Fanconi anemia, complementation group A (FANCA) [MIM:227650]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:10094191, ECO:0000269|PubMed:10210316, ECO:0000269|PubMed:10521298, ECO:0000269|PubMed:10807541, ECO:0000269|PubMed:11091222, ECO:0000269|PubMed:17924555, ECO:0000269|PubMed:9371798, ECO:0000269|PubMed:9399890, ECO:0000269|PubMed:9929978}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23385	0.24341	-0.101294944	45.66525124	1788.01434	7.80511	0.453	0.107	T	0.002	0.090	B	0.001	0.040	B	0.510	0.118	N	1	0.090	P	0.97	0.241	L	-1.74	0.834	D	-2.45	0.535	N	0.065	0.246	-1.101	0.040	T	0.000	0.000	T	.	.	.	-1.202	0.025	0.006	0.374	0.024	0.033	0.083	N	c	-1.452	-1.469	0.022	0.134	0.707	0.730	0	-2.44	0.061	0.074	0.144	-0.701	0.038	0.000	0.063	0.002	0.062	2.101	0.034	.	ENSG00000187741.10|ENSG00000204991.6|ENSG00000204991.6|ENSG00000187741.10|ENSG00000204991.6|ENSG00000204991.6|ENSG00000258947.2|ENSG00000141002.14|ENSG00000204991.6|ENSG00000178773.10|ENSG00000187741.10|ENSG00000204991.6|ENSG00000204991.6|ENSG00000204991.6|ENSG00000187741.10|ENSG00000187741.10|ENSG00000204991.6|ENSG00000187741.10|ENSG00000140995.12|ENSG00000204991.6|ENSG00000003249.9|ENSG00000204991.6|ENSG00000256390.1|ENSG00000204991.6|ENSG00000256390.1	Adipose_Subcutaneous|Adipose_Subcutaneous|Artery_Aorta|Artery_Tibial|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Pancreas|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Testis|Testis|Whole_Blood	0.5	65	136	chr16	89839766	chr16:89839766	G	C	65	PASS	AN=2;DP=136	GT	0/1
chr17	1012138	1012138	-	C	intronic	ABR	.	.	.	0.999949479	5.05E-05	1.49E-12	.	0.59342	.	-1.03976177	7.802547771	211.79342	3.13829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	285	chr17	1012138	chr17:1012138	G	GC	57	PASS	AN=2;DP=285	GT	0/1
chr17	4173433	4173433	-	A	UTR3	UBE2G1	NM_003342:c.*2415_*2416insT	.	.	0.745694457	0.252001968	0.002303575	.	0.70845	0.18619	0.013025609	54.62962963	2.97356	0.10769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	34	chr17	4173433	chr17:4173433	T	TA	78	PASS	AN=2;DP=34	GT	0/1
chr17	9497478	9497478	-	T	intronic	CFAP52	.	.	.	.	.	.	.	0.04801	0.09789	-0.617221851	17.44515216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	100	chr17	9497478	chr17:9497478	C	CT	64	PASS	AN=2;DP=100	GT	0/1
chr17	10552000	10552000	-	T	intronic	MYH3	.	.	.	3.60E-13	0.999999918	8.17E-08	DISEASE: Arthrogryposis, distal, 2A (DA2A) [MIM:193700]: A form of distal arthrogryposis, a disease characterized by congenital joint contractures that mainly involve two or more distal parts of the limbs, in the absence of a primary neurological or muscle disease. DA2A is characterized by contractures of the hands and feet, oropharyngeal abnormalities, scoliosis, and a distinctive face that includes a very small oral orifice, puckered lips, and an H- shaped dimple of the chin. {ECO:0000269|PubMed:16642020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Arthrogryposis, distal, 2B (DA2B) [MIM:601680]: A form of distal arthrogryposis, a disease characterized by congenital joint contractures that mainly involve two or more distal parts of the limbs, in the absence of a primary neurological or muscle disease. DA2B is characterized by contractures of the hands and feet, and a distinctive face characterized by prominent nasolabial folds, small mouth and downslanting palpebral fissures. {ECO:0000269|PubMed:16642020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Arthrogryposis, distal, 8 (DA8) [MIM:178110]: A form of distal arthrogryposis, a disease characterized by congenital joint contractures that mainly involve two or more distal parts of the limbs, in the absence of a primary neurological or muscle disease. {ECO:0000269|PubMed:25957469}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43095	0.21181	-1.554570334	3.225996697	602.04688	4.96558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	33	chr17	10552000	chr17:10552000	A	AT	76	PASS	AN=2;DP=33	GT	0/1
chr17	19651700	19651700	-	A	UTR5	ALDH3A1	NM_000691:c.-3259_-3258insT;NM_001330150:c.-4982_-4981insT	.	.	1.33E-12	0.012994368	0.987005632	.	0.38989	.	0.113945049	62.14319415	3022.02935	10.43597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	228	chr17	19651700	chr17:19651700	G	GA	53	PASS	AN=2;DP=228	GT	0/1
chr17	20769722	20769722	A	T	intronic	CCDC144NL	.	.	.	8.14E-06	0.171830686	0.828161171	.	.	.	1.26585432	93.59518754	271.43253	3.53005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	277	chr17	20769722	chr17:20769722	A	T	.	PASS	AN=0;DP=277	GT	0/1
chr17	25910015	25910015	-	C	exonic	KSR1	.	frameshift insertion	KSR1:NM_014238:exon5:c.454dupC:p.P155Tfs*21	0.609182271	0.390802697	1.50E-05	.	0.30789	0.15135	.	.	702.71821	5.27148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	466	chr17	25910015	chr17:25910015	G	GC	79	PASS	AN=2;DP=466	GT	0/1
chr17	26522835	26522835	T	-	UTR3	NLK	NM_016231:c.*1173delT	.	.	0.998934347	0.001065641	1.24E-08	.	0.96706	0.16306	-0.494039303	22.09247464	16.84134	0.5932	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	169	chr17	26522834	chr17:26522834	AT	A	89	PASS	AN=2;DP=169	GT	0/1
chr17	30320861	30320861	-	T	intronic	SUZ12	.	.	.	0.999270636	0.000729363	9.92E-10	DISEASE: Note=A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. {ECO:0000269|PubMed:11371647}.; 	0.90035	.	-0.159704656	41.90846898	37.06069	1.10711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	106	chr17	30320860	chr17:30320860	CT	CTT,C	66	PASS	AN=2;DP=106	GT	0/1
chr17	30320861	30320861	T	-	intronic	SUZ12	.	.	.	0.999270636	0.000729363	9.92E-10	DISEASE: Note=A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. {ECO:0000269|PubMed:11371647}.; 	0.90035	.	-0.159704656	41.90846898	37.06069	1.10711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	106	chr17	30320860	chr17:30320860	CT	CTT,C	66	PASS	AN=2;DP=106	GT	0/1
chr17	30327962	30327962	A	-	UTR3	SUZ12	NM_015355:c.*1940delA;NM_001321207:c.*1940delA	.	.	0.999270636	0.000729363	9.92E-10	DISEASE: Note=A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. {ECO:0000269|PubMed:11371647}.; 	0.90035	.	-0.159704656	41.90846898	37.06069	1.10711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	25	chr17	30327961	chr17:30327961	TA	T	41	PASS	AN=2;DP=25	GT	0/1
chr17	48940282	48940282	A	-	UTR3	TOB1	NM_001243885:c.*59delT;NM_001243877:c.*59delT;NM_005749:c.*59delT	.	.	0.798204384	0.196185003	0.005610612	.	0.78741	0.22085	-0.271755481	34.31823543	36.86645	1.10425	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	301	chr17	48940281	chr17:48940281	GA	G,GAA	75	PASS	AN=2;DP=301	GT	0/1
chr17	48940282	48940282	-	A	UTR3	TOB1	NM_001243885:c.*58_*59insT;NM_001243877:c.*58_*59insT;NM_005749:c.*58_*59insT	.	.	0.798204384	0.196185003	0.005610612	.	0.78741	0.22085	-0.271755481	34.31823543	36.86645	1.10425	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	301	chr17	48940281	chr17:48940281	GA	G,GAA	75	PASS	AN=2;DP=301	GT	0/1
chr17	57762402	57762402	-	T	intronic	CLTC	.	.	.	0.999999993	6.69E-09	1.07E-22	.	0.64701	0.94571	-1.3098007	4.847841472	29.64323	0.94706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	50	chr17	57762402	chr17:57762402	C	CT	84	PASS	AN=2;DP=50	GT	0/1
chr17	72368450	72368450	C	T	exonic	GPR142	.	nonsynonymous SNV	GPR142:NM_001331076:exon4:c.C836T:p.T279I,GPR142:NM_001331077:exon4:c.C836T:p.T279I,GPR142:NM_181790:exon4:c.C1100T:p.T367I	5.60E-05	0.689421967	0.310522078	.	.	.	-0.214928658	37.7388535	583.16278	4.89646	0.463	0.086	T	0.166	0.295	B	0.038	0.234	B	0.120	0.190	N	0.982	0.250	N	0.14	0.088	N	-0.36	0.688	T	0.17	0.051	N	0.156	0.186	-1.036	0.187	T	0.105	0.384	T	0.027	0.500	D	1.117	0.202	11.31	0.909	0.196	0.315	0.241	N	c	-0.610	-0.497	0.068	0.155	0.497	0.185	0	3.63	0.406	2.018	0.404	0.925	0.434	0.005	0.169	0.980	0.490	6.953	0.236	GPCR, rhodopsin-like, 7TM	.	.	0.5	.	206	chr17	72368450	chr17:72368450	C	T	.	PASS	AN=0;DP=206	GT	0/1
chr17	73518210	73518210	A	T	exonic	TSEN54	.	nonsynonymous SNV	TSEN54:NM_207346:exon8:c.A1048T:p.R350W	1.76E-05	0.878799611	0.121182822	DISEASE: Pontocerebellar hypoplasia 4 (PCH4) [MIM:225753]: A disorder characterized by an abnormally small cerebellum and brainstem, severe neonatal encephalopathy, microcephaly, myoclonus and muscular hypertonia. There is a severe inferior olivary and pontine neuronal loss and a diffuse white matter gliosis. {ECO:0000269|PubMed:18711368, ECO:0000269|PubMed:21824568}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pontocerebellar hypoplasia 2A (PCH2A) [MIM:277470]: A disorder characterized by an abnormally small cerebellum and brainstem, and progressive microcephaly from birth combined with extrapyramidal dyskinesia. Severe chorea occurs and epilepsy is frequent. There are no signs of spinal cord anterior horn cells degeneration. {ECO:0000269|PubMed:18711368, ECO:0000269|PubMed:23307886}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pontocerebellar hypoplasia 5 (PCH5) [MIM:610204]: A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum. Brain MRI shows an abnormally small cerebellum and brainstem, decreased cerebral white matter, and a thin corpus callosum. {ECO:0000269|PubMed:21368912}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1309	0.10259	1.664578456	96.27860344	7072.81561	18.04186	0.001	0.784	D	0.991	0.622	D	0.726	0.533	P	0.051	0.230	N	1	0.090	N	1.79	0.469	L	0.21	0.600	T	-3.83	0.721	D	0.308	0.369	-0.625	0.638	T	0.213	0.574	T	0.050	0.643	D	0.691	0.160	8.767	0.596	0.061	0.087	0.144	N	c	-0.954	-1.235	1.000	0.427	0.706	0.609	0	-7.6	0.012	-0.258	0.087	-1.110	0.018	0.000	0.063	0.006	0.095	14.221	0.652	.	.	.	0.5	105	247	chr17	73518210	chr17:73518210	A	T	105	PASS	AN=2;DP=247	GT	0/1
chr17	79092197	79092197	A	G	UTR3	AATK	NM_001080395:c.*5T>C;NM_004920:c.*5T>C	.	.	0.806763652	0.193192255	4.41E-05	.	0.24713	0.12093	.	.	2421.6539	9.14383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	473	chr17	79092197	chr17:79092197	A	G	72	PASS	AN=2;DP=473	GT	0/1
chr17	79092204	79092204	A	G	exonic	AATK	.	stoploss	AATK:NM_004920:exon13:c.T3814C:p.X1272R,AATK:NM_001080395:exon14:c.T4123C:p.X1375R	0.806763652	0.193192255	4.41E-05	.	0.24713	0.12093	.	.	2421.6539	9.14383	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1.767	0.273	14.79	0.783	0.118	0.222	0.214	N	c	0.413	0.067	1.000	0.747	0.079	0.017	2	2.46	0.289	1.062	0.300	0.977	0.596	0.009	0.180	0.524	0.275	4.001	0.090	.	.	.	0.5	74	488	chr17	79092204	chr17:79092204	A	G	74	PASS	AN=2;DP=488	GT	0/1
chr17	79176011	79176011	C	-	intronic	CEP131	.	.	.	.	.	.	.	0.11345	0.14275	2.688316751	98.8794527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	303	chr17	79176010	chr17:79176010	GC	G	71	PASS	AN=2;DP=303	GT	0/1
chr18	61231145	61231148	AAAT	-	intronic	SERPINB12	.	.	.	7.76E-17	0.000298875	0.999701125	.	0.64256	0.12241	0.64123826	83.97617363	445.92863	4.39516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	15.85	61	chr18	61231144	chr18:61231144	AAAAT	A	15.85	PASS	AN=0;DP=61	GT	0/1
chr18	66358515	66358516	AA	-	exonic	TMX3	.	stopgain	TMX3:NM_001350513:exon8:c.572_573del:p.F191fs*0	0.191322508	0.808583205	9.43E-05	.	0.25561	0.11004	0.240763792	69.36777542	113.00046	2.31345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	43	chr18	66358514	chr18:66358514	TAA	T	109	PASS	AN=2;DP=43	GT	0/1
chr19	1506040	1506040	G	A	exonic	ADAMTSL5	.	synonymous SNV	ADAMTSL5:NM_213604:exon12:c.C1390T:p.L464L	3.22E-10	0.086390501	0.913609499	.	0.15136	0.10435	0.442818085	77.8544468	191.46176	3.00098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	291	chr19	1506040	chr19:1506040	G	A	125	PASS	AN=2;DP=291	GT	0/1
chr19	12024208	12024208	-	T	intronic	ZNF69	.	.	.	7.35E-05	0.303763702	0.696162787	.	.	.	0.25917371	70.05779665	27.23843	0.8772	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	21	chr19	12024208	chr19:12024208	C	CT	44	PASS	AN=2;DP=21	GT	0/1
chr19	12430216	12430216	-	A	exonic	ZNF563	.	frameshift insertion	ZNF563:NM_145276:exon4:c.622dupT:p.W208Lfs*8	8.58E-07	0.745959735	0.254039407	.	0.19969	.	-0.179930907	40.35739561	73.78661	1.79524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	303	chr19	12430216	chr19:12430216	C	CA	65	PASS	AN=2;DP=303	GT	0/1
chr19	13064214	13064214	C	-	UTR3	RAD23A	NM_001270363:c.*351delC;NM_005053:c.*351delC;NM_001270362:c.*351delC	.	.	0.039256536	0.953968382	0.006775082	.	0.75777	0.19913	0.373041938	75.29488087	343.62896	3.93038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	263	chr19	13064213	chr19:13064213	AC	A	82	PASS	AN=2;DP=263	GT	0/1
chr19	14910637	14910637	-	A	exonic	OR7C1	.	frameshift insertion	OR7C1:NM_198944:exon1:c.311dupT:p.T105Hfs*16	0.22002709	0.647565891	0.132407019	.	0.04419	.	1.68481378	96.37886294	1256.02466	6.68179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	204	chr19	14910637	chr19:14910637	G	GA	74	PASS	AN=2;DP=204	GT	0/1
chr19	22942325	22942325	G	C	exonic	ZNF99	.	nonsynonymous SNV	ZNF99:NM_001080409:exon4:c.C386G:p.A129G	3.04E-09	0.162337151	0.837662846	.	.	.	.	.	1840.35634	7.91225	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-2.115	0.002	N	3.24	0.069	T	1.63	0.006	N	0.112	0.121	-0.995	0.313	T	0.000	0.000	T	.	.	.	-1.238	0.024	0.006	0.266	0.013	0.001	0.006	N	c	-2.131	-2.096	0.000	0.012	0.487	0.133	0	-0.806	0.103	-1.663	0.021	-1.836	0.006	0.000	0.063	0.000	0.016	4.388	0.107	.	ENSG00000229676.2|ENSG00000229676.2|ENSG00000261558.1|ENSG00000229676.2	Adipose_Subcutaneous|Cells_Transformed_fibroblasts|Testis|Testis	0.5	76	21	chr19	22942325	chr19:22942325	G	C	76	PASS	AN=2;DP=21	GT	0/1
chr19	36632054	36632054	C	T	exonic	CAPNS1	.	synonymous SNV	CAPNS1:NM_001003962:exon2:c.C141T:p.G47G,CAPNS1:NM_001302632:exon2:c.C141T:p.G47G,CAPNS1:NM_001749:exon2:c.C141T:p.G47G	0.00012438	0.955664809	0.044210811	.	0.08365	0.34122	-0.273576253	33.97027601	297.0565	3.67821	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	180	chr19	36632054	chr19:36632054	C	T	.	PASS	AN=0;DP=180	GT	0/1
chr19	42594356	42594356	-	T	UTR3	POU2F2	NM_001247994:c.*1400_*1401insA;NM_002698:c.*1347_*1348insA;NM_001207025:c.*1347_*1348insA	.	.	0.97379428	0.026199392	6.33E-06	.	0.49246	0.27788	-0.538132194	20.26421326	113.2753	2.31761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.53	104	chr19	42594356	chr19:42594356	A	AT	14.53	PASS	AN=0;DP=104	GT	0/1
chr19	43697581	43697581	C	T	intronic	PSG4	.	.	.	7.90E-10	0.142725513	0.857274486	.	.	.	2.180909934	98.08327436	470.5539	4.48902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	123	chr19	43697581	chr19:43697581	C	T	91	PASS	AN=2;DP=123	GT	0/1
chr19	43763145	43763145	G	A	exonic	PSG9	.	synonymous SNV	PSG9:NM_001301707:exon3:c.C573T:p.P191P,PSG9:NM_002784:exon4:c.C852T:p.P284P	2.75E-14	0.004925661	0.995074339	.	0.24972	.	1.607548084	95.91884879	1896.34765	8.00804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	661	chr19	43763145	chr19:43763145	G	A	86	PASS	AN=2;DP=661	GT	0/1
chr19	47656347	47656347	-	T	intronic	SAE1	.	.	.	0.988952422	0.011043848	3.73E-06	.	0.6322	0.12546	-0.380166007	27.88393489	72.606	1.77749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	165	chr19	47656347	chr19:47656347	C	CT	92	PASS	AN=2;DP=165	GT	0/1
chr19	48533848	48533848	A	-	intronic	CABP5	.	.	.	0.004220803	0.864684114	0.131095083	.	0.35156	0.12664	1.216305531	93.13517339	1299.91454	6.78329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	121	chr19	48533847	chr19:48533847	GA	G	92	PASS	AN=2;DP=121	GT	0/1
chr19	49550848	49550848	-	TG	downstream	CGB8	dist=47	.	.	0.091777955	0.569050721	0.339171324	.	.	0.0808	.	.	2.44485	0.08929	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	471	chr19	49550848	chr19:49550848	C	CTG	71	PASS	AN=2;DP=471	GT	0/1
chr19	49606750	49606750	C	-	intronic	SNRNP70	.	.	.	0.993095086	0.006904675	2.39E-07	.	0.54826	0.24974	.	.	34.51837	1.05414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	491	chr19	49606749	chr19:49606749	TC	T	75	PASS	AN=2;DP=491	GT	0/1
chr19	53818738	53818738	-	G	intergenic	BIRC8;ZNF845	dist=23863;dist=18234	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	22.12	139	chr19	53818738	chr19:53818738	T	TG	22.12	PASS	AN=0;DP=139	GT	0/1
chr19	58063707	58063707	C	G	intronic	ZNF550	.	.	.	1.52E-10	0.015432932	0.984567068	.	0.13325	.	0.643056625	84.05284265	61.39768	1.59674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	59	chr19	58063707	chr19:58063707	C	G	57	PASS	AN=2;DP=59	GT	0/1
chr19	58446550	58446550	G	A	UTR5	ZNF418	NM_133460:c.-1360C>T;NM_001317027:c.-2687C>T;NM_001317030:c.-7257C>T	.	.	4.09E-21	0.000634817	0.999365183	.	0.14679	.	0.07167258	59.15899976	147.26502	2.64424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	686	chr19	58446550	chr19:58446550	G	A	.	PASS	AN=0;DP=686	GT	0/1
chr20	21143813	21143813	-	T	intronic	KIZ	.	.	.	.	.	.	DISEASE: Retinitis pigmentosa 69 (RP69) [MIM:615780]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:24680887}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.03855	0.06663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	145	chr20	21143813	chr20:21143813	A	AT	62	PASS	AN=2;DP=145	GT	0/1
chr20	32256055	32256055	G	-	UTR3	ACTL10	NM_001024675:c.*14delG	.	.	0.001052601	0.375410156	0.623537243	.	0.16929	.	.	.	42.92503	1.24244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	185	chr20	32256054	chr20:32256054	TG	T	73	PASS	AN=2;DP=185	GT	0/1
chr21	10959812	10959812	A	-	intronic	TPTE	.	.	.	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	321	chr21	10959811	chr21:10959811	CA	C	87	PASS	AN=2;DP=321	GT	0/1
chr21	18924237	18924237	T	G	exonic	CXADR	.	synonymous SNV	CXADR:NM_001207063:exon3:c.T381G:p.G127G,CXADR:NM_001207064:exon3:c.T381G:p.G127G,CXADR:NM_001207066:exon3:c.T381G:p.G127G,CXADR:NM_001338:exon3:c.T381G:p.G127G	0.342891275	0.654169916	0.00293881	.	.	0.2281	-0.005381972	53.50908233	105.35884	2.22286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	173	chr21	18924237	chr21:18924237	T	G	100	PASS	AN=2;DP=173	GT	0/1
chr21	31874286	31874286	G	A	exonic	KRTAP19-5	.	synonymous SNV	KRTAP19-5:NM_181611:exon1:c.C123T:p.Y41Y	0.005182713	0.465959289	0.528857998	.	0.07982	.	-0.229483771	36.86010852	22.09493	0.74262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	861	chr21	31874286	chr21:31874286	G	A	100	PASS	AN=2;DP=861	GT	0/1
chr21	33078562	33078562	T	A	intronic	SCAF4	.	.	.	0.999999693	3.07E-07	5.92E-18	.	0.7639	0.10408	-1.214341017	5.67940552	104.06406	2.20474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	103	chr21	33078562	chr21:33078562	T	A	79	PASS	AN=2;DP=103	GT	0/1
chr21	33078569	33078569	G	A	intronic	SCAF4	.	.	.	0.999999693	3.07E-07	5.92E-18	.	0.7639	0.10408	-1.214341017	5.67940552	104.06406	2.20474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	chr21	33078569	chr21:33078569	G	A	.	PASS	AN=0;DP=59	GT	0/1
chr22	21470406	21470406	C	T	ncRNA_intronic	BCRP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	578	chr22	21470406	chr22:21470406	C	T	.	PASS	AN=0;DP=578	GT	0/1
chr22	21583596	21583597	CT	-	intronic	GGT2	.	.	.	0.80481651	0.190051731	0.005131759	.	.	0.11718	.	.	1425.85016	7.053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	83	chr22	21583595	chr22:21583595	ACT	A	105	PASS	AN=2;DP=83	GT	0/1
chr22	28191059	28191059	A	-	intronic	MN1	.	.	.	.	.	.	DISEASE: Note=A chromosomal aberration involving MN1 may be a cause of acute myeloid leukemia (AML). Translocation t(12;22)(p13;q11) with ETV6. {ECO:0000269|PubMed:7731705}.; DISEASE: Note=Defects in MN1 involved in the development of meningiomas, slowly growing benign tumors derived from the arachnoidal cap cells of the leptomeninges, the soft coverings of the brain and spinal cord. Meningiomas are believed to be the most common primary tumors of the central nervous system in man. {ECO:0000269|PubMed:7731706}.; 	0.29108	.	.	.	959.02985	5.99624	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	175	chr22	28191058	chr22:28191058	GA	G	77	PASS	AN=2;DP=175	GT	0/1
chr22	39496323	39496325	AAC	-	exonic	APOBEC3H	.	nonframeshift deletion	APOBEC3H:NM_001166002:exon2:c.40_42del:p.N15del,APOBEC3H:NM_001166003:exon2:c.40_42del:p.N15del,APOBEC3H:NM_001166004:exon2:c.40_42del:p.N15del,APOBEC3H:NM_181773:exon2:c.40_42del:p.N15del	0.637623187	0.355699123	0.00667769	.	0.03807	0.11857	0.705562627	85.52724699	3553.79975	11.52391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	75	chr22	39496322	chr22:39496322	TAAC	T	129	PASS	AN=2;DP=75	GT	0/1
chr22	39496336	39496336	G	T	exonic	APOBEC3H	.	nonsynonymous SNV	APOBEC3H:NM_001166002:exon2:c.G53T:p.R18L,APOBEC3H:NM_001166003:exon2:c.G53T:p.R18L,APOBEC3H:NM_001166004:exon2:c.G53T:p.R18L,APOBEC3H:NM_181773:exon2:c.G53T:p.R18L	0.637623187	0.355699123	0.00667769	.	0.03807	0.11857	0.705562627	85.52724699	3553.79975	11.52391	0.142	0.270	T	0.989	0.609	D	0.925	0.643	D	.	.	.	1	0.090	P	1.845	0.488	L	0.04	0.634	T	-2.22	0.501	N	0.173	0.210	-1.017	0.247	T	0.000	0.000	T	.	.	.	2.007	0.302	16.25	0.986	0.437	0.019	0.058	N	c	-0.661	-0.923	1.000	0.517	0.560	0.301	0	-0.212	0.125	-0.116	0.106	-0.317	0.077	0.000	0.063	0.000	0.016	5.159	0.143	Cytidine and deoxycytidylate deaminases, zinc-binding	ENSG00000226024.1|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000226024.1|ENSG00000239713.3|ENSG00000239713.3|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000128394.12|ENSG00000239713.3|ENSG00000226024.1|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000226024.1|ENSG00000239713.3|ENSG00000226024.1|ENSG00000226024.1|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000226024.1|ENSG00000239713.3|ENSG00000239713.3|ENSG00000239713.3	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Artery_Aorta|Artery_Tibial|Artery_Tibial|Breast_Mammary_Tissue|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Lung|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Thyroid|Vagina	0.5	127	76	chr22	39496336	chr22:39496336	G	T	127	PASS	AN=2;DP=76	GT	0/1
chrX	22012649	22012649	-	T	UTR3	SMS	NM_004595:c.*180_*181insT;NM_001258423:c.*180_*181insT	.	.	0.921460277	0.078440686	9.90E-05	DISEASE: X-linked syndromic mental retardation Snyder-Robinson type (MRXSSR) [MIM:309583]: Characterized by moderate intellectual deficit, hypotonia, an unsteady gait, osteoporosis, kyphoscoliosis and facial asymmetry. Transmission is X-linked recessive. {ECO:0000269|PubMed:14508504, ECO:0000269|PubMed:22612257}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.58047	0.10879	-0.295622497	32.61972163	8.98969	0.33022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	163	chrX	22012649	chrX:22012649	G	GT	76	PASS	AN=2;DP=163	GT	0/1
chrX	38214650	38214650	-	A	intronic	OTC	.	.	.	0.9810179	0.01896801	1.41E-05	DISEASE: Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]: An X-linked disorder of the urea cycle which causes a form of hyperammonemia. Mutations with no residual enzyme activity are always expressed in hemizygote males by a very severe neonatal hyperammonemic coma that generally proves to be fatal. Heterozygous females are either asymptomatic or express orotic aciduria spontaneously or after protein intake. The disorder is treatable with supplemental dietary arginine and low protein diet. The arbitrary classification of patients into the 'neonatal' group (clinical hyperammonemia in the first few days of life) and 'late' onset (clinical presentation after the neonatal period) has been used to differentiate severe from mild forms. {ECO:0000269|PubMed:10070627, ECO:0000269|PubMed:10502831, ECO:0000269|PubMed:10737985, ECO:0000269|PubMed:11793483, ECO:0000269|PubMed:1480464, ECO:0000269|PubMed:1671317, ECO:0000269|PubMed:1721894, ECO:0000269|PubMed:2347583, ECO:0000269|PubMed:2474822, ECO:0000269|PubMed:3170748, ECO:0000269|PubMed:7474905, ECO:0000269|PubMed:7951259, ECO:0000269|PubMed:8019569, ECO:0000269|PubMed:8081373, ECO:0000269|PubMed:8081398, ECO:0000269|PubMed:8099056, ECO:0000269|PubMed:8530002, ECO:0000269|PubMed:8807340, ECO:0000269|PubMed:8830175, ECO:0000269|PubMed:8956038, ECO:0000269|PubMed:8956045, ECO:0000269|PubMed:9143919, ECO:0000269|PubMed:9266388, ECO:0000269|PubMed:9286441, ECO:0000269|PubMed:9452024, ECO:0000269|PubMed:9452049, ECO:0000269|PubMed:9452065, ECO:0000269|Ref.32, ECO:0000269|Ref.43}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22278	0.85665	0.082802743	60.09082331	1072.1412	6.27812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	107	chrX	38214650	chrX:38214650	T	TA	67	PASS	AN=2;DP=107	GT	0/1
chrX	47494977	47494977	-	A	UTR3	ELK1	NM_001114123:c.*1250_*1251insT;NM_001257168:c.*1371_*1372insT;NM_005229:c.*1250_*1251insT	.	.	0.756057874	0.234569302	0.009372824	.	0.99996	0.15613	0.327131069	73.27199811	572.0593	4.85348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	224	chrX	47494976	chrX:47494976	GA	GAA,G	85	PASS	AN=2;DP=224	GT	0/1
chrX	47494977	47494977	A	-	UTR3	ELK1	NM_001114123:c.*1251delT;NM_001257168:c.*1372delT;NM_005229:c.*1251delT	.	.	0.756057874	0.234569302	0.009372824	.	0.99996	0.15613	0.327131069	73.27199811	572.0593	4.85348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	224	chrX	47494976	chrX:47494976	GA	GAA,G	85	PASS	AN=2;DP=224	GT	0/1
chrX	118774740	118774740	C	T	exonic	SEPT6	.	synonymous SNV	SEPT6:NM_015129:exon6:c.G702A:p.P234P,SEPT6:NM_145799:exon6:c.G702A:p.P234P,SEPT6:NM_145800:exon6:c.G702A:p.P234P,SEPT6:NM_145802:exon6:c.G702A:p.P234P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	147	chrX	118774740	chrX:118774740	C	T	58	PASS	AN=2;DP=147	GT	0/1
chrX	119658624	119658624	-	T	UTR3	CUL4B	NM_003588:c.*1991_*1992insA;NM_001330624:c.*1991_*1992insA;NM_001079872:c.*1991_*1992insA	.	.	0.999846678	0.000153322	1.10E-10	DISEASE: Mental retardation, X-linked, syndromic, 15 (MRXS15) [MIM:300354]: A syndromic form of X-linked mental retardation characterized by severe intellectual deficit associated with short stature, craniofacial dysmorphism, small testes, muscle wasting in lower legs, kyphosis, joint hyperextensibility, pes cavus, small feet, and abnormalities of the toes. Additional neurologic manifestations include speech delay and impairment, tremor, seizures, gait ataxia, hyperactivity and decreased attention span. {ECO:0000269|PubMed:17236139, ECO:0000269|PubMed:17273978, ECO:0000269|PubMed:19377476, ECO:0000269|PubMed:20002452}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87445	0.12121	-0.361761279	28.6329323	9.19638	0.33598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	124	chrX	119658624	chrX:119658624	C	CT	113	PASS	AN=2;DP=124	GT	0/1
